ISSN 0233-7657. Biopolymers and Cell. 2010. Vol. 26. N 2
Vitamin D – a novel role in pregnancy
Chander P. Arora , C. J. Hobel
1, 2
1, 2
1
Cedars-Sinai Medical Center, Burns-Allen Research Institute and the Division of Maternal-Fetal Medicine
8635, West Third St., Ste 160W, Los Angeles, CA, USA, 90048
2
David Geffen School of Medicine, University of California Los Angeles
10833, Le Conte Avenue, Los Angeles, CA, USA, 90095
arora@cshs.org
Vitamin D regulates placental development and function. It is a potent regulator of the immune systemstimulating antimicrobial responses while suppressing inflammation. Its deficiency has been linked to
increased risk of serious chronic and inflammatory diseases. Vitamin D deficiency during pregnancy increases susceptibility to infection and inflammation, leading, in turn, to outcome like preterm birth or
preeclampsia. Pregnant women with darker skin pigmentation are more likely to be vitamin D deficient,
particularly when living in regions with low exposure to sunlight. It is possible that during pregnancy, a
primary non-infectious inflammatory process is activated by vitamin D deficiency. Combined assessment of
vitamin D deficiency and inflammatory markers in early pregnancy or during different stages of pregnancy
may facilitate the recognition of the risk of complications.
Keywords: vitamin D, pregnancy, immune response.
Introduction. Beyond its classical effects on bone and
calcium homeostasis causing rickets and osteoporosis,
vitamin D has become increasingly recognized as a potent regulator of multiple physiological functions. Vitamin D can be obtained from limited food sources,
such as fatty fish and fish oil, and, today, from dietary
supplements or we can also make it ourselves, through
a chemical reaction that happens in the skin when it is
exposed to ultraviolet B (UVB) light especially to meet
the increased demands of pregnancy.
The vitamin D deficiency epidemic during pregnancy is caused by a lack of adequate sunlight exposure
needed to synthesize vitamin D3 (cholecalciferol) in the
skin, coupled with oral intakes that are too low even
with regular use of prenatal vitamins containing 400 IU
vitamin D3 [1]. Vitamin D deficiency during pregnanÓ Institute of Molecular Biology and Genetics NAS of Ukraine, 2010
cy has been linked with a number of serious short- and
long-term health problems in offspring, including impaired growth, skeletal problems, type 1 diabetes, asthma, and schizophrenia [2].
Functional aspects of vitamin D. Vitamin D in
humans, refers to Vitamin D3, which is also known as
cholecalciferol. In response to UVB light, it is created
by skin cells called keratinocytes utilizing 7-dehydrocholesterol, a product of cholesterol. This version has
no biological activity in the body till this molecule is
modified primarily in the liver, by a series of related enzymes for hydroxylation, to generate 25-hydroxyvitamin D3 (25(OH)D3). The 25(OH)D3 made by the liver
is nonetheless the major circulating form of vitamin D.
When it is needed in the body, a final conversion to the
biologically active form by the enzyme 1a-hydroxylase (CYP27b1), is required to become 1,25-dihydroxyvitamin D (1,25(OH)2D3). This was first discovered in
97
CHANDER P. ARORA, HOBEL C. J.
20
18
7-dehydro-cholesterol
11
9
12
Skin
(Keratinocytes)
HO
17
26
23
27
15
25
8
OH
7
6
4
3
24 25
22
21
5
2
CH2
10
1
Vit D (D3 / Cholocalciferol)
25
CH2
OH
HO
Liver
25(OH) Vit D3 (circulating form)
CH2
1 a-hydroxylase
(CYP27b1)
Kidneys
and
other tissues
1
HO
OH
1,25(OH)2 Vit D3 (active form)
Fig. 1. Skin keratinocytes convert 7-dehydrocholesterol to vitamin D in response to sunlight exposure. This is converted to the circulating
form 25(OH)D 3 in liver and to 1,25(OH) 2D 3 in the target tissues
the kidney, and renal processing is responsible for generating much of the body’s circulating 1,25(OH)2D3
supply [3] (Fig. 1).
The active form of vitamin D, the 1,25(OH)2D3 molecule virtually functions as an «on/off» switch for genes of every tissue in the human body. This form of vitamin D acts by attaching to the vitamin D receptor
(VDR), which serves as a transcription factor inside a
cell’s nucleus. Once bound to 1,25(OH)2D3, the VDR
protein makes a complex with retinoid-x receptor
(RXR). This complex now binds to a specific region of
the cell’s DNA adjacent to a target gene. Their attachment to the DNA induces cellular machinery to begin
transcribing the neighboring gene to a specific protein.
Recently, many other tissues, including cells of the
immune system and the skin, have been identified to
perform the conversion of 25(OH)D3. Skin is therefore
unique among organs in that it is capable of manufacturing biologically active 1,25(OH)2D3 in the presence of
UVB light from start to finish, although local production of 1,25(OH)2D3 from circulating in other tissues is
a substantial source of vitamin D’s biological activity.
98
By inducing a cell to make a particular protein,
1,25(OH)2D3 affects a range of cellular function, and
this ability to trigger gene activity in different tissues is
the basis of vitamin D’s enormous physiological effects. Precisely, vitamin D is manufactured in one tissue and circulates through the body influencing many
other tissues, and VDR is a nuclear receptor that responds to powerful steroidal hormones such as estrogen and testosterone [4].
At least 1,000 different genes are believed to be
regulated by 1,25(OH)2D3, including several involved
in the body’s calcium processing that account for D’s
well-known role in bone formation as well as genes
with critical roles in a variety of cellular defenses.
Circulating levels of 25(OH)D3 – the biomarker
of vitamin D status. Circulating levels of 25(OH)D3
are a direct reflection of vitamin D status, which depends on access to vitamin D either through exposure
to sunlight or through dietary intake whereas serum
concentrations of 1,25(OH)2D3, are primarily defined
by the endocrine regulators of renal CYP27b1 activity.
The net effect of this is that vitamin D status can vary
VITAMIN D – A NOVEL ROLE IN PREGNANCY
25(OH) D
Sufficient
30–60 ng per milliliter
or 75–150 nmol/l
1ahydroxylase
1,25(OH)2 D
Active Form (Target Tissues)
Insufficient
20–30 ng per milliliter
or 50–75 nmol/l
Deficient
20 ng per milliliter
or 50 nmol/l
Fig. 2. Deficient and Sufficient levels of circulating vitamin D for
getting converted to the active form by the action of 1a-hydroxylase
significantly in populations as a consequence of geographical, social or economic factors. Until recently,
rickets was considered to be the only significant clinical consequence of low serum 25(OH)D3. However, an
entirely new perspective on vitamin D deficiency has
arisen from the observation that serum 25(OH)D3 levels correlate inversely with serum parathyroid hormone below a threshold of 80 nmol/l 25(OH)D3 [5].
This has led to a complete re-evaluation of the optimal
serum level of 25(OH)D3 so that serum concentrations
of 25(OH)D3 up to 75 nmol/l are now considered to be
inadequate and are more commonly referred to as vitamin D «insufficiency» as opposed to «deficiency» [6].
A 25(OH)D3 level of 30 ng per milliliter (75 nmol/l) or
higher provides adequate substrate for 1-OHase to convert 25(OH)D3 to its active form, 1,25(OH)2D3 [6]. We
categorized the serum levels of 25(OH)D3 as: less than
50 nmol/l (< 20 ng per milliliter) as deficient, 50–
75 nmol/l (< 20–30 ng per milliliter) as insufficient,
and 75–150 nmol/l (< 30–60 ng per milliliter) as sufficient (Fig. 2).
Once 1,25(OH)2D3 completes the task of maintaining normal cellular proliferation and differentiation, it
induces expression of the enzyme 25-hydroxyvitamin
D-24-hydroxylase (24-OHase), which enhances the catabolism of 1,25(OH)2D3 to biologically inert 1,24,25trihydroxyvitamin D.
Locally produced 1,25(OH)2D3 does not enter the
circulation and has no influence on calcium metabolism. Therefore circulating levels of 25(OH)D3 are a direct reflection of vitamin D status, which depends on
access to vitamin D either through exposure to sunlight
or through dietary intake.
Vitamin D requirements during pregnancy. In
addition to causing poor global mineralization of the
skeleton, vitamin D deficiency has implications for numerous other nonskeletal health outcomes. In utero or
early life vitamin D deficiency has been linked to an increased risk of type 1 diabetes [7], asthma [8], and
schizophrenia [9, 10].
Fascinating new data also show that vitamin D regulates placental development and function [11],
which suggests that maternal vitamin D status may be
associated with adverse outcomes of pregnancy, such
as miscarriage, preeclampsia, and preterm birth.
Preterm delivery in the environment of infection is
believed to result from the actions of pro-inflammatory
cytokines secreted as part of the maternal and/or fetal
host response to microbial invasion [12, 13]. Enhanced
expression of the pro-inflammatory cytokines IL-1,
IL-6 and TNFa are associated with preterm delivery
[14]. Such cytokines have been detected in elevated
concentrations in the amniotic fluid and plasma of women with preterm labor and human gestational tissues
are potentially rich sources of inflammatory cytokines
[15]. These cytokines can be induced by a number of
stimuli, including bacterial endotoxins, and they have
been shown to promote spontaneous labor and rupture
of membranes via their actions on the gestational tissues [16–18].
Several studies have reported altered levels of
CYP27b1 in placentas from preeclampsia pregnancies
[19, 20]. Furthermore, in a recent nested case-control
study of pregnant women Bodnar and colleagues
showed that vitamin D deficiency significantly increases the risk of preeclampsia [1]. This coupled with
evidence of the prevalence of vitamin D insufficiency
in pregnant mothers – particularly African-American
mothers [1] – has supported a role for vitamin D sufficiency in protecting against this prevalent complication
99
CHANDER P. ARORA, HOBEL C. J.
of pregnancy [21]. There was no significantly altered
expression of vitamin D receptor (VDR) or CYP27b1
in pregnancies with intrauterine growth restriction
(IUGR) [22]. More recent studies of vitamin D insufficiency during pregnancy and lactation have served to
underline the magnitude of the problem [1, 3, 4, 23,
24].
Our research group recently reported vitamin D deficiency in a cohort study of spontaneous preterm pregnancies (N = 27) compared to matched case controls
(N = 32) in an NIH Behavior In Pregnancy Study
(BIPS). In the study, serum samples were collected in
528 ethnically diverse women at 18–20 weeks (T1),
28–30 weeks (T2) and 34–36 weeks (T3). The results
indicated deficient vitamin D status in the subjects who
delivered preterm (PTB group) but sufficient vitamin D
levels in controls at all three visits. We assessed the involvement of vitamin D in the occurrence of IL-6 levels
in women with spontaneous preterm birth. At all three
time intervals, significantly higher levels of IL-6 were
associated with the preterm birth cases as compared to
the controls [25]. Significantly higher levels of this
pro-inflammatory cytokine, IL-6 were found in subjects with IUGR as compared with controls. This also
correlated with lower serum vitamin D levels in this cohort. It is possible that a non-infectious inflammatory
response is activated by vitamin D deficiency that is a
marker of risk for or causative in preterm birth or development of IUGR [26].
Racial disparity in vitamin D synthesis. Since the
most important source of vitamin D is the skin’s synthesis of the vitamin from UVB solar radiation [27].
Any process that reduces UVB photons from entering
the epidermis will diminish cholecalciferol (vitamin
D3) production. The skin pigment melanin absorbs
UVB photons and can reduce vitamin D3 synthesis by
90 % [28]. Consequently, African Americans are at
high risk of vitamin D deficiency.
According to CDC, 42 % of African-American
women in US between the ages of 15–49 years are deficient in vitamin D (less than 20 ng per milliliter of serum levels) [29]. Nevertheless, it is also clear that some
groups are more at risk of vitamin D insufficiency than
others. The 1988–1994 National Health and Nutrition
Examination Survey revealed that 42 % of AfricanAmerican women of child-bearing age had 25(OH)D3
100
levels that were lower than 50 nmol/l, half the current
optimal target level. This compares with only 4 % of
white women [23].
We recently reported vitamin deficiency in cohort
study of African-American pregnancies compared to
Caucasians. Although the cohort used had women who
delivered at term, the levels of 25(OH)D3 in Caucasians
were significantly lower in the subjects with infection
than the ones without (p < .001). Women with vitamin
D insufficiency in the second trimester were more
likely to develop infection during pregnancy but not
subjects with sufficient vitamin D at T1. The proportion of infection percent in the Caucasian and AfricanAmerican groups was significantly different at all the
time periods as well as their levels of 25(OH)D3. African Americans show a trend to have higher proportion
of infections than the Caucasian group at all three visits
and had significantly lower 25(OH)D3 (p < .001) at these visits [30].
Our results reveal a positive association between
25(OH)D3 concentrations and elevated risk of infection
[31]. Vitamin D insufficiency may, therefore be involved in the pathogenesis of maternal infection during
pregnancy. Vitamin D levels could modulate this infection susceptibility during pregnancy.
In another study, approximately 29 % of Black pregnant women and 5 % of white pregnant women residing in the northeastern United States had vitamin D deficiency, i. e. serum 25(OH)D3 of less than 50 nmol/l,
whereas 54 % of Black women and 47 % of white women had serum 25(OH)D3 levels indicative of vitamin
D insufficiency, i. e. 25(OH)D3 of 50–75 nmol/l [1].
Immunomodulation by vitamin D. Recently vitamin D deficiency and even insufficiency has become
a worldwide issue affecting the populations across the
globe. The broader implications of vitamin D restrictions especially with the growing trend of sun-blocks,
have become more evident. Vitamin D status has been
found to be a major contributing factor to immune response [32]. Precisely, the active form of vitamin D,
1,25(OH)2D3 has been shown to be the key modulator
of immune responses [33, 34]. The degree to which inflammatory pathways play a role in labors that are not
associated with clinical signs of infection is unknown,
however even normal labor shares certain characteristics with inflammatory processes.
VITAMIN D – A NOVEL ROLE IN PREGNANCY
Fig. 3. Macrophage cells respond to bacterial cell walls by manufacturing both VDR proteins and the enzyme (1-OHase) that
converts circulating 25(OH)D 3 into the biologically active
1,25(OH)2D 3. These events induced the immune cells to start producing cathelicidin that demonstrates antimicrobial activity against
a variety of bacteria
Liu [35] substantially advanced this line of investigation by showing that human immune cells respond to
infection by manufacturing both vitamin D receptor
proteins and the enzyme that converts circulating
25(OH)D3 into the biologically active 1,25(OH)2D3 and
to induce the immune cells to start producing cathelicidin. Cathelicidin, the naturally produced antimicrobial agent that acts against a variety of bacteria, explaining the tuberculosis sunshine cure: the sun-soaked skin
could boost their immune cells to generate the natural
antibiotic that fought off the tuberculosis bacteria (TB)
(Fig. 3).
In particular, the active form of vitamin D,
1,25(OH)2D3 has been shown to be a key modulator of
immune responses [36, 37]. Both the receptor for
1,25(OH)2D3, VDR [36, 38] and the enzyme that catalyzes the synthesis of 1,25(OH)2D3 from precursor
25(OH)D, CYP27b1 [39, 40] are abundantly expressed
by cells from the immune system. The presence of
CYP27b1 in macrophages [41] and dendritic cells [42]
indicates that local (autocrine 25(OH)D3 or paracrine)
synthesis of 1,25(OH)2D3 is a pivotal feature of vitamin
D action within the immune system.
Placental production of vitamin D. The placenta
was one of the first extra-renal sites shown to synthesize 1,25(OH)2D3 from 25(OH)D3 [43, 44]. Organiza-
tion of 1a-hydroxylase, the enzyme needed to convert
25(OH)D3 to the active form is localized both in maternal decidua and fetal trophoblasts and is more abundant
in first and second trimester. We detected highest levels
of 25(OH)D3 at 18–20 weeks of pregnancy in the study
as well as control group. This could also be due to the
presence of VDR in the placenta as has been suggested
by Bruns and Bruns [45].
This means that vitamin D functions in an autocrine
fashion at the fetal-maternal interface [45]. One possible explanation is that 1,25(OH)2D3 functions as a regulator of placental calcium transport in addition to an
immunomodulatory function [46].
From the studies highlighting immunological function of the heterogeneous cells that make up the placenta, maternal and fetal cells are able to mediate innate
[47, 48] and adaptive [49, 50] immune responses. Furthermore, a series of studies using human placentas
[11, 22] have demonstrated the expression of CYP27b1
(gene for producing the enzyme 1a-hydroxylase) in
decidua (maternal tissue) and trophoblast (fetal tissue)
[11, 22]. Within deciduas, CYP27b1 is expressed by
both stromal cells and macrophages, while in trophoblasts CYP27b1 is localized predominantly in the
syncytiotrophoblast (the cells that form the barrier between maternal and fetal blood) [22]. In primary cultures of human decidual cells, both 1,25(OH)2D3 and
25(OH)D3 (the latter metabolized endogenously to
1,25(OH)2D3) induced expression of antimicrobial cathelcidin, but suppressed the inflammatory cytokine
production [32].
Within the decidua, the gene expression for this enzyme (CYP27b1) was identified in decidual stromal
cells as well as the decidual macrophages, suggesting a
possible immunomodulatory function for localized
synthesis of 1,25(OH)2D3 [11, 22]. Vitamin D appears
to be the trigger for antibacterial/anti-inflammatory responses in decidual and trophoblastic cells.
Analysis of decidual cells in vitro has endorsed a
possible role for 25(OH)D3 and 1,25(OH)2D3 as modulators of immune responses in maternal tissue [32]. Human decidual cells from 1st trimester placentas incubated for 24 hrs with 25(OH)D3 or 1,25(OH)2D3 showed
induction of cathelicidin and suppression of cytokines
such as IL-1, TNFa and IL-4 [32]. The fact that a physiological dose of 25(OH)D3 (100 nmol/l) was as ef101
CHANDER P. ARORA, HOBEL C. J.
fective as a pharmacological dose of 1,25(OH)2D3
(100 nmol/l), underlines the importance of localized
(placental) versus endocrine (systemic) synthesis of
1,25(OH)2D3.
Using primary human placental tissue and trophoblastic cells it has been shown that the fetal side of the
placenta also induces cathelicidin-mediated antibacterial response to treatment with vitamin D metabolites.
Collectively these data indicate that exogenous
1,25(OH)2D3 or locally metabolized 25(OH)D3 are capable of inducing anti-bacterial and anti-inflammatory
responses in both the maternal and fetal components of
the placenta [22].
In addition to stromal and trophoblastic cells, the
placenta is made up of an array of leukocytes that are
fundamental to the immunology of gestation. It has been shown that the most abundant of the decidual immune cells, uNK, do not express CYP27b1 [22] but are potential targets for paracrine responses to 1,25(OH)2D3
synthesized by stromal cells or macrophages. By contrast, decidual macrophages express abundant levels of
CYP27b1 and may therefore support the same autocrine vitamin D-induced innate immunity demonstrated in peripheral blood-derived macrophages. In the
case of the latter the specific antibacterial responses
such as toll-like receptor (TLR)-mediated induction of
cathelicidin are highly dependent on vitamin D status
[51].
When a macrophage or monocyte is stimulated
through its toll-like receptor 2/1 (TLR2/1) by an infectious agent such as Mycobacterium tuberculosis or
pathogen-associated molecules such as lipopolysaccharide, the signal up-regulates expression of the VDR
and the enzyme D-1a- hydroxylase (1-OHase), stimulating the production of active vitamin D. The active
form 1,25(OH)2D3 travels to the nucleus, where it increases the expression of cathelicidin, a peptide capable of promoting innate immunity and inducing the destruction of infectious agents such as M. tuberculosis.
Human cathelicidin antimicrobial peptide (CAMP)
gene is a direct target of the VDR and is strongly upregulated in myeloid cells by 1,25-dihydroxyvitamin
D3 [51]. It is also likely that the 1,25(OH)2D3 produced
in monocytes or macrophages is released to act locally
on activated T lymphocytes, which regulate cytokine
synthesis, and activated B lymphocytes, which regulate
102
immunoglobulin synthesis. The autocrine synthesis of
1,25(OH)2D3 that drives innate immune responses is
dependent on the availability of substrate 25(OH)D3
(Fig. 3). It has been shown that Caucasian levels of
cathelicidin production were 3-times higher than those
in African Americans [51]. In vitro supplementation of
25(OH)D3 to the African-American serum was able to
restore cathelicidin expression to levels similar to the
ones for Caucasians establishing that vitamin D deficiency compromises innate immune responses to infection [52].
The placenta is one of the first tissues shown to be
capable of synthesizing 1,25 (OH)2D3 with 1a-hydroxylase receptor activity detected both in maternal decidua and fetal trophoblast [19].
The net effect is that vitamin D status can vary significantly in populations as a consequence of stress
from social, behavioral and/or economic factors. Sensitivity of parathyroid hormone to the threshold of
80 nmol/l of 25(OH)D3 has led to re-evaluation of the
optimal level up to 75 nmol/l are now considered to be
inadequate and are more commonly referred to as vitamin D insufficiency as opposed to deficiency [53].
A newborn’s vitamin D stores are completely reliant on vitamin D from the mother [13]. Not surprisingly, poor maternal vitamin D status during pregnancy
is a major risk factor for infant rickets [54]. This could
be indicative of the fact that fetal programming is associated with the increased risk of common diseases in
adult life.
×. Ï. Àðîðà, Ê. Äæ. Õîáåëü
³òàìè í D – íîâà ðîëü ïðè âàã³òíîñò³
Ðåçþìå
³òàì³í D ðå ãóëþº ðîçâè òîê ³ ôóíêö³þ ïëàöåíòè. Â³í º ïî òóæ íèì ðåãóëÿòîðîì ³ìóííî¿ ñèñòåìè, ùî ñòèìóëþº àíòèáàêòåð³éíó â³äïîâ³äü òà ïðè ãí³÷óº çàïàëåííÿ. Éîãî äåô³öèò ïðèçâîäèòü äî çðîñòàííÿ ðèçèêó ñåðéîçíèõ õðîí³÷íèõ ³ çàïàëüíèõ
çàõâî ðþâàíü. Ïðî òÿ ãîì âàã³òíîñò³ äåô³öèò â³òàì³íó D ï³äâè ùóº ñïðèéíÿòëèâ³ñòü æ³íîê äî ³íôåêö³é ³ çàïàëåííÿ, ñïðè ÷è íÿº
ïåðåä÷àñí³ ïîëîãè òà ïðå åêëàìïñ³þ. Âàã³òí³ æ³íêè ç òåìí³øîþ
ï³ãìåíòàö³ºþ øê³ðè, ÿê³ æèâóòü ó ì³ñöÿõ ç íèç ü êèì ð³âíåì ñî íÿ÷íîãî ñâ³òëà, ÷àñò³øå ñòðàæ äà þòü â³ä äåô³öèòó â³òàì³íó
D. Ïðè âàã³òíîñò³ ìîæëèâà àêòèâàö³ÿ ïåðâèííîãî íå³íôåêö³éíîãî çàïàëüíîãî ïðîöåñó âíàñë³äîê íåñòà÷³ â³òàì³íó D. Âè ÿâ ëåííÿ äåô³öèòó â³òàì³íó D ³ çà ïàëü íèõ ìàð êåð³â íà ð³çíèõ
ñòàä³ÿõ âàã³òíîñò³ ìîæå ïîëåãøèòè ðîçï³çíàâàííÿ ðèçèêó
áóäü-ÿêèõ óñêëàäíåíü.
Êëþ ÷îâ³ ñëî âà: â³òàì³í D, âàã³òí³ñòü, ³ìóííà â³äïîâ³äü.
VITAMIN D – A NOVEL ROLE IN PREGNANCY
×. Ï. Àðîðà, Ê. Äæ. Õîáåëü
Âè òàìèí D – íîâàÿ ðîëü ïðè áå ðåìåí íîñòè
Ðåçþìå
Âèòàìèí D ðåãóëèðóåò ðàçâèòèå è ôóíêöèþ ïëàöåíòû. Îí ÿâ ëÿåòñÿ ìîùíûì ðåãóëÿòîðîì èììóííîé ñèñòåìû, ñòèìóëèðóÿ
àíòèáàêòåðèàëüíûé îòâåò è ïîäàâëÿÿ âîñïàëåíèå. Åãî äåôè öèò ïðèâîäèò ê óâåëè÷åíèþ ðèñêà ñåðüåçíûõ õðîíè÷åñêèõ è âîñ ïàëèòåëüíûõ çàáîëåâàíèé. Âî âðåìÿ áåðåìåííîñòè äåôèöèò
âèòàìèíà D óâåëè÷èâàåò âîñïðèèì÷èâîñòü æåíùèí ê èíôåêöèÿì è âîñïàëåíèþ, âûçûâàåò ïðåæäåâðåìåííûå ðîäû è ïðåýêëàìïñèþ. Áåðåìåííûå æåíùèíû ñ áîëåå òåìíîé ïèãìåíòàöèåé
êîæè, æèâóùèå â îáëàñòÿõ ñ íèçêèì óðîâíåì ñîëíå÷íîãî ñâå òà, ÷àùå ïîäâåðæåíû äåôèöèòó âèòàìèíà D. Ïðè áåðåìåííîñòè âîçìîæíà àêòèâàöèÿ ïåðâè÷íîãî íåèíôåêöèîííîãî âîñïà ëèòåëüíîãî ïðîöåññà âñëåäñòâèå íåäîñòàòêà âèòàìèíà D. Âûÿâëåíèå äåôèöèòà âèòàìèíà D è âîñïàëèòåëüíûõ ìàðêåðîâ íà
ðàçëè÷íûõ ñòàäèÿõ áåðåìåííîñòè ìîæåò îáëåã÷èòü ðàñïîçíàâàíèå ðèñêà âñåâîçìîæíûõ îñëîæíåíèé.
Êëþ÷åâûå ñëîâà: âèòàìèí D, áåðåìåííîñòü, èììóííûé îò âåò.
REFERENCES
1. Bodnar L. M., Simhan H. N., Powers R. W., Frank M. P.,
Cooperstein E., Roberts, J. M. High prevalence of vitamin D
insufficiency in black and white pregnant women residing in
the northern United States and their neonates // J. Nutr.–
2007.–137, N 2.–P. 447–452.
2. Holick M. F. Resurrection of vitamin D deficiency and rickets
// J. Clin. Invest.–2006.–116, N 8.–P. 2062–2072.
3. Hollis B. W., Wagner C. L. Nutritional vitamin D status during pregnancy: reasons for concern // CMAJ Canad. Med.
Assoc. J.–2006.–174, N 9.–P. 1287–1290.
4. Hollis B. W., Wagner C. L. Vitamin D deficiency during pregnancy: an ongoing epidemic // Amer. J. Clin. Nutr.–2006.–
84, N 2.–P. 273.
5. Chapuy M. C., Preziosi P., Maamer M., Arnaud S., Galan P.,
Hercberg S., Meunier P. J. Prevalence of vitamin D insufficiency in an adult normal population // Osteopor. Int.–1997.–
7, N 5.–P. 439–443.
6. Dawson-Hughes B., Heaney R. P., Holick M. F., Lips P., Meunier P. J., Vieth R. Estimates of optimal vitamin D status //
Osteopor. Int.–2005.–16, N 7.–P. 713–716.
7. Stene L. C., Joner G., and Norwe gian Childhood Diabetes
Study Group. Use of cod liver oil during the first year of life is
associated with lower risk of childhood-onset type 1 diabetes:
a large, population-based, case-control study // Am. J. Clin.
Nutr.–2003.–78, N 6.–P. 1128–1134.
8. Camargo C. A. Jr., Rifas-Shiman S. L., Litonjua A. A., RichEdwards J. W., Weiss S. T., Gold D. R., Kleinman K., Gillman
M. W. Maternal intake of vitamin D during pregnancy and
risk of recurrent wheeze in children at 3 y of age // Am. J.
Clin. Nutr.–2007.–85, N 3.–P. 788–795.
9. McGrath J. Hy pothesis: is low prenatal vitamin D a risk-modifying factor for schizophrenia? // Schizophr. Res.–1999.–
40, N 3.–P. 173–177.
10. McGrath J., Saari K., Hakko H., Jokelainen J., Jones P., Jarvelin M. R., Chant D., Isohanni M. Vitamin D supplementation during the first year of life and risk of schizophrenia: a
Finnish birth cohort study // Schizophr. Res.–2004.–67, N 2–
3.–P. 237–245.
11. Evans K. N., Bulmer J. N., Kilby M. D., Hewison M. Vitamin
D and placental-decidual function // J. Soc. Gynecol. In vest.–
2004.–11, N 5.–P. 263–271.
12. Romero R., Espinoza J., Goncalves L. F., Kusanovic J. P.,
Friel L. A., Nien J. K. Inflammation in preterm and term labour and delivery // Semin. Fe tal and Neonat. Med.–2006.–11,
N 5.–P. 317–326.
13. Romero R., Espinoza J., Goncalves L. F., Kusanovic J. P.,
Friel L., Hassan S. The role of inflammation and infection in
preterm birth // Semin. Reproduct. Med.–2007.–25, N 1.–
P. 21–39.
14. Hillier S. L., Witkin S. S., Krohn M. A., Watts D. H., Kiviat N.
B., Eschenbach D. A. The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection,
histologic chorioamnionitis, and chorioamnion infection //
Obstet. and Gynecol.–1993.–81, N 6.–P. 941–948.
15. Gravett M. G., Novy M. J., Rosenfeld R. G., Reddy A. P., Jacob T., Turner M., McCormack A., Lapidus J. A., Hitti J.,
Eschenbach D. A., Rob erts C. T. Jr., Nagalla S. R. Diagnosis
of intra-amniotic infection by proteomic profiling and identification of novel biomarkers // JAMA.–2004.–292, N 4.–
P. 462–469.
16. El-Shazly S., Makhseed M., Azizieh F., Raghupathy R. Increased expression of pro-inflammatory cytokines in placentas of women undergoing spontaneous preterm delivery or
premature rupture of membranes // Am. J. Reprod. Immun.–
2004.–52, N 1.–P. 45–52.
17. Blank V., Hirsch E., Challis J. R., Romero R., Lye S. J. Cytokine signaling, inflammation, innate immunity and preterm
labour – a workshop report // Placenta.–2008.–29, Suppl 1.–
P. 102–104.
18. Gomez R., Romero R., Edwin S. S., David C. Pathogenesis of
preterm labor and preterm premature rupture of membranes
associated with intraamniotic infection // Infect. Dis. Clin.
North Amer.–1997.–11, N 1.–P. 135–176.
19. Fischer D., Schroer A., Ludders D., Cordes T., Bucker B.,
Reichrath J., Friedrich M. Metabo lism of vitamin D 3 in the
placental tissue of normal and preeclampsia complicated
pregnancies and premature births // Clin. Exp. Obstet. Gynecol.–2007.–34, N 2.–P. 80–84.
20. Diaz L., Arranz C., Avila E., Halhali A., Vilchis F., Larrea F.
Ex pression and activity of 25-hydroxyvitamin D-1 alpha-hydroxylase are restricted in cultures of human syncytiotrophoblast cells from preeclamptic pregnancies // J. Clin. Endocrinol. Metabol.–2002.–87, N 8.–P. 3876–3882.
21. Hypponen E. Vitamin D for the prevention of preeclampsia?
A hy pothesis // Nutr. Rev.–2005.–63, N 7.–P. 225–232.
22. Zehnder D., Evans K. N., Kilby M. D., Bulmer J. N., Innes B.
A., Stewart P. M., Hewison M. The ontogeny of 25-hydroxyvitamin D(3) 1a-hydroxylase expression in human placenta
and decidua // Am. J. Pathol.–2002.–161, N 1.–P. 105–114.
23. Nesby-O’Dell S., Scanlon K. S., Cogswell M. E., Gillespie C.,
Hollis B. W., Looker A. C., Allen C., Doughertly C., Gunter E.
W., Bowman B. A. Hypovitaminosis D prev alence and determinants among African American and white women of reproductive age: third Nat. Health and Nutr. Ex amination Survey,
1988–1994 // Am. J. Clin. Nutr.–2002.–76, N 1.–P. 187–192.
24. Hollis B. W., Wagner C. L. Assessment of dietary vitamin D
requirements during pregnancy and lactation // Amer. J. Clin.
Nutr.–2004.–79, N 5.–P. 717–726.
103
CHANDER P. ARORA, HOBEL C. J.
25. Arora C. P., Hobel C. J. Vitamin D and IL-6 in pregnancies
with subsequent preterm birth // Reprod. Sci.–2010.–17.–
179À–180À. Sage Publ.
26. Hobel C. J., Arora C. P., Adeniji A., Arora P., Jackman S. E.,
Miadel O., Baldiyan L. Circulating levels of vitamin D and
IL-6 in pregnancies with IUGR // Reprod. Sci.–2008.–15,
N 2, suppl.–121A–122A. Sage Publ.
27. Holick M. F. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis // Am. J.
Clin. Nutr.–2004.–79, N 3.–P. 362–371.
28. Clem ens T. L., Adams J. S., Henderson S. L., Holick M. F. Increased skin pigment reduces the capacity of skin to synthesise vitamin D 3 // Lancet.–1982.–319, N 8263.–P. 74–76.
29.Centers for Disease Control and Prevention (CDC). Differences in infant mortality between blacks and whites – United
States, 1980–1991 // MMWR – Morbidity & Mortality Weekly Report.–1994.–43, N 16.–P. 288–289.
30. Arora C. P., Adeniji A., Jackman S. E., Forooghi B., Mostadim I., Yadegari P., Hobel C. J. Re duced plasma levels of vitamin D in Caucasian women at term are associated with increased rate of infection // Reprod. Sci.–2008.–15, N 2,
suppl.–183A. Sage Publ.
31. Adeniji A., Arora C. P., Baldiyan L., Miadel O., Arora P., Ortega M., Le A., Koenig M., Hobel C. J. Reduced vitamin D levels in African American pregnancies are associated with increased rate of infection // Reprod. Sci.–2008.–15, N 2,
suppl.–187A. Sage Publ.
32. Ev ans K. N., Nguyen L., Chan J., Innes B. A., Bulmer J. N.,
Kilby M. D., Hewison M. Effects of 25-hydroxyvitamin D3
and 1,25-dihydroxyvitamin D3 on cytokine production by human decidual cells // Biol. Reprod.–2006.–75, N 6.–P. 816–
822.
33. Mathieu C. van, Etten E., Decallonne B., Guilietti A., Gysemans C., Bouillon R., Overbergh L. Vitamin D and 1,25-dihydroxyvitamin D3 as modulators in the immune system // J.
Steroid Biochem. and Mol. Biol.–2004.–89–90, N 1–5.–
P. 449–452.
34. Ad ams J. S., Liu P. T., Chun R., Modlin R. L., Hewison M. Vitamin D in defense of the human immune response // Ann. N.
Y. Acad. Sci.–2007.–1117.–P. 94–105.
35. Liu H., Redline R. W., Han Y. W. Fusobacterium nucleatum
induces fetal death in mice via stimulation of TLR4-mediated
placental inflammatory response // J. Immunol.–2007.–179,
N 4.–P. 2501–2508.
36. Cantorna M. T., Zhu Y., Froicu M., Wittke A. Vitamin D sta tus, 1,25-dihydroxyvitamin D3 , and the immune system //
Am. J. Clin. Nutr.–2004.–80, N 6, suppl.–P. 1717S–1720S.
37. Griffin M. D., Xing N., Kumar R. Vitamin D and its analogs as
regulators of immune activation and antigen presentation //
Ann. Rev. Nutr.–2003.–23.–P. 117–145.
38. Deluca H. F., Cantorna M. T. Vitamin D: its role and uses in
immunology // FASEB J.–2001.–15, N 14.–P. 2579–2585.
39. Townsend K., Ev ans K. N., Camp bell M. J., Colston K. W.,
Ad ams J. S., Hewison M. Biological actions of extra-renal
25-hydroxyvitamin D-1alpha-hydroxylase and implications
for chemoprevention and treatment // J. Steroid Biochem. and
Mol. Biol.–2005.–97, N 1–2.–P. 103–109.
40. Hewison M., Zehnder D., Chakraverty R., Ad ams J. S. Vi tamin D and barrier function: a novel role for extra-renal 1 al-
pha-hydroxylase // Mol. and Cell. Endocrinol.–2004.–215,
N 1–2.–P. 31–38.
41. Kreutz M., Andreesen R., Krause S. W., Szabo A., Ritz E.,
Reichel H. 1,25-dihydroxyvitamin D3 production and vitamin
D 3 receptor expression are developmentally regulated during
differentiation of human monocytes into macrophages //
Blood.–1993.–82, N 4.–P. 1300–1307.
42. Hewison M., Free man L., Hughes S. V., Evans K. N., Bland
R., Eliopoulos A. G., Kilby M. D., Moss P. A., Chakraverty R.
Differential regulation of vitamin D receptor and its ligand in
human monocyte-derived dendritic cells // J. Immunol.–
2003.–170, N 11.–P. 5382–5390.
43. Gray T. K., Lester G. E., Lorenc R. S. Evidence for extra-renal 1 alpha-hydroxylation of 25-hydroxyvitamin D3 in pregnancy // Science.–1979.–204, N 4399.–P. 1311–1313.
44. Weisman Y., Harell A., Edelstein S., Da vid M., Spirer Z., Golander A. 1 alpha, 25-Dihydroxyvitamin D 3 and 24,25-dihydroxyvitamin D3 in vi tro synthesis by human decidua and placenta // Nature.–1979.–281, N 5729.–P. 317–319.
45. Bruns M. E., Bruns D. E. Vitamin D metabolism and function
during pregnancy and the neonatal period // Ann. Clin. Lab.
Sci.–1983.–13, N 6.–P. 521–530.
46. Re but-Bonneton C., Demignon J. Effects of 1,25-dihydroxyvitamin D 3 on in vi tro lymphocyte reactions: arguments for
a role at the maternofetal interface // Gynecol. Obstet. In vest.–1991.–32, N 3.–P. 134–138.
47. Sacks G., Sargent I., Redman C. An innate view of human
pregnancy // Immunol. Today.–1999.–20, N 3.–P. 114–118.
48. Guleria I., Pollard J. W. The trophoblast is a component of
the innate immune system during pregnancy // Nat. Med.–
2000.–6, N 5.–P. 589–593.
49. Zenclussen A. C., Schumacher A., Zenclussen M. L., Wafula
P., Volk H. D. Immunology of pregnancy: cellular mechanisms allowing fetal survival within the maternal uterus // Expert Rev. Mol. Med.–2007.–9, N 10.–P. 1–14.
50. Laskarin G., Kammerer U., Rukavina D., Thomson A. W.,
Fernandez N., Blois S. M. Antigen-presenting cells and materno-fetal tolerance: an emerging role for dendritic cells //
Am. J. Reprod. Immunol.–2007.–58, N 3.–P. 255–267.
51. Liu P. T., Stenger S., Li H., Wenzel L., Tan B. H., Krutzik S.
R., Ochoa M. T., Schauber J., Wu K., Meinken C., Kamen D.
L., Wag ner M., Bals R., Steinmeyer A., Zugel U., Gallo R. L.,
Eisenberg D., Hewison M., Hollis B. W., Adams J. S., Bloom
B. R., Modlin R. L. Toll-like receptor triggering of a vitamin
D-mediated human antimicrobial response // Science.–
2006.–311, N 5768.–P. 1770–1773.
52. Ad ams J. S., Hewison M. Unexpected actions of vitamin D:
new per spectives on the regulation of innate and adaptive
immunity // Nat. Clin. Pract. Endocrinol. Metabol.–2008.–4,
N 2.–P. 80–90.
53. Bodnar L. M., Krohn M. A., Simhan H. N. Maternal vitamin D
deficiency is associated with bacterial vaginosis in the first
trimester of pregnancy // J. Nutr.–2009.–139, N 6.–P. 1157–
1161.
54. Fiscella K. Racial disparity in infant and maternal mortality:
confluence of infection, and microvascular dysfunction //
Matern. and Child Health J.–2004.–8, N 2.–P. 45–54.
UDC 577.161.22; 618.2
Received 10.01.10
104
")/,/'9
#ELL $EFENSES AND THE
6ITAMIN
3CIENTISTS NOW RECOGNIZE THAT VITAMIN $ DOES MUCH MORE THAN BUILD
STRONG BONES AND THAT MANY PEOPLE ARE NOT GETTING ENOUGH OF IT
)S WIDESPREAD $ DElCIENCY CONTRIBUTING TO MAJOR ILLNESSES
+%9 #/.#%043
N
N
N
6ITAMIN $ LONG ASSOCIATED ONLY
WITH ITS ROLE IN BONE FORMATION
IS ACTUALLY ACTIVE THROUGHOUT
THE HUMAN BODY POWERFULLY IN
mUENCING IMMUNE SYSTEM RE
SPONSES AND CELL DEFENSES
)T CAN BE OBTAINED FROM FOOD OR
MANUFACTURED BY HUMAN SKIN
EXPOSED TO SUNLIGHT -EASURES
OF VITAMIN $ LEVELS SHOW HOW
EVER THAT MANY PEOPLE HAVE TOO
LITTLE OF IT CIRCULATING IN THEIR
BLOOD TO PROTECT HEALTH
#LEAR ASSOCIATIONS BETWEEN LOW
VITAMIN $ LEVELS AND CANCERS
AUTOIMMUNITY INFECTIOUS DIS
EASES AND OTHER CONDITIONS SUG
GEST THAT CURRENT DAILY INTAKE
RECOMMENDATIONS FOR THIS CRITI
CAL NUTRIENT NEED REVISION
ÅI]Z:Y^idgh
+' 3 # ) % . 4 ) & ) # ! - % 2 ) # ! .
)
ÌÊÜ>ÃÊV>i`ÊÌ iÊÃÕÃ iÊVÕÀi]Ê>`ÊÊ
Ì iÊi>ÀÞÊÓäÌ ÊViÌÕÀÞ]ÊLivÀiÊÌ iÊiÀ>Ê
vÊ>ÌLÌVÃ]ÊÌÊÜ>ÃÊÌ iÊÞÊivviVÌÛiÊ
Ì iÀ>«ÞÊvÀÊÌÕLiÀVÕÃÃÊÜ°Ê ÊiÊ
iÜÊÜ ÞÊÌÊÜÀi`]ÊÕÃÌÊÌ >ÌÊ/ Ê«>ÌiÌÃÊ
ÃiÌÊÌÊÀiÃÌÊÊÃÕÞÊV>iÃÊÜiÀiÊvÌiÊ
ÀiÃÌÀi`ÊÌÊ i>Ì °Ê/ iÊÃ>iʺÌÀi>ÌiÌ»Ê
>`ÊLiiÊ`ÃVÛiÀi`ÊÊ£nÓÓÊvÀÊ>Ì iÀÊ
ÃÌÀVÊ ÃVÕÀ}i]Ê ÀViÌÃ p >Ê `ivÀ}Ê
V ` `ÊV`ÌÊV>ÕÃi`ÊLÞÊ>Ê>L
ÌÞÊÌÊ>iÊ >À`ii`ÊLi°Ê,ViÌÃÊ >`Ê
LiiÊÊÌ iÊÀÃiÊÊ£nÌ Ê>`Ê£Ì ViÌÕÀÞÊ
ÕÀ«i]ÊVV`}ÊÜÌ Ê`ÕÃÌÀ>â>ÌÊ
>`Ê Ì iÊ ÛiiÌÊ vÊ «i«iÊ vÀÊ Ì iÊ
VÕÌÀÞÃ`iÊÌÊÌ iÊ«ÕÌi`ÊVÌiÃ]ÊÜ iÊ>Ê
7>ÀÃ>ÜÊ`VÌÀÊLÃiÀÛi`ÊÌ >ÌÊÌ iÊ«ÀLiÊ
Ü>ÃÊÀi>ÌÛiÞÊÀ>ÀiÊÊÀÕÀ>Ê*Ã ÊV `Ài°Ê
iÊLi}>ÊiÝ«iÀiÌ}ÊÜÌ ÊVÌÞÊV
`ÀiÊ>`ÊvÕ`ÊÌ >ÌÊ iÊVÕ`ÊVÕÀiÊÌ iÀÊ
ÀViÌÃÊÜÌ ÊiÝ«ÃÕÀiÊÌÊÃÕà iÊ>i°Ê
ÞÊ£nÓ{ÊiÀ>ÊÃViÌÃÌÃÊvÕ`ÊÌ >ÌÊ
V`ÛiÀÊÊ>ÃÊ >`ÊiÝViiÌÊ>ÌÀViÌÃÊ
«À«iÀÌiÃ]Ê>Ì Õ} ÊÌ >ÌÊÌÀi>ÌiÌÊ``Ê
ÌÊV>ÌV ÊÊÜ`iÞ]ÊÊ«>ÀÌÊLiV>ÕÃiÊÌ iÊ
«ÃÃLÌÞÊÌ >ÌÊ>Êv`Ê} ÌÊVÌ>ÊÕ
"*9,/ÊÓääÇÊ-
ÃiiÊVÀÕÌÀiÌÃÊ«ÀÌ>ÌÊÌÊ i>Ì Ê
Ü>ÃÊÌÊÞiÌÊÕ`iÀÃÌ`ÊLÞÊ`VÌÀðÊ`Ê
i>ÀÞÊ>ÊViÌÕÀÞÊÜÕ`Ê«>ÃÃÊLivÀiÊÃVi
ÌÃÌÃÊ>`iÊÌ iÊViVÌÊLiÌÜiiÊÃÕV Ê
`iÌ>ÀÞÊVÕÀiÃÊvÀÊÀViÌÃÊ>`ÊÌ iÊLiiwV>Ê
ivviVÌÃÊvÊÃÕà i°Ê >ÀÞÊÓäÌ ViÌÕÀÞÊÀi
Ãi>ÀV iÀÃÊ Ã Üi`Ê Ì >ÌÊ ÀÀ>`>Ìi`Ê Ã]Ê
Ü iÊvi`ÊÌÊÀ>ÌÃÊÜÌ Ê>ÀÌwV>ÞÊ`ÕVi`Ê
ÀViÌÃ]Ê >`ÊÌ iÊÃ>iÊVÕÀ>ÌÛiÊ«À«iÀÌiÃÊ
>ÃÊV`ÛiÀÊ°Ê/ iÊVÀÌV>ÊVÊii
iÌÊÊÌ iÊÃÊ>`ÊÌ iÊÊÜ>ÃÊw>ÞÊ
`iÌwi`ÊÊ£ÓÓÊ>`Ê`ÕLLi`ÊÛÌ>Ê °Ê
ÞÊÌ iÊÌ iÊ`i>ÊvʺÛÌ>Ê>iÃ]»ÊÀÊÛÌ>
Ã]ÊÜ>ÃÊ>Ê««Õ>ÀÊiÜÊÃViÌwVÊÌ«V]Ê
>`ÊÃÕLÃiµÕiÌÊÀiÃi>ÀV ÊÌÊÌ iÊvÕV
ÌÃÊvÊÛÌ>Ê ÊÊÌ iÊL`ÞÊÜ>ÃÊÛiÀÞÊ
ÕV Êà >«i`ÊLÞÊ ½ÃÊ>}iÊ>ÃÊiÊvÊÌ ÃiÊ
iÃÃiÌ>ÊVÀÕÌÀiÌÃÊÌ >ÌÊ Õ>ÃÊV>Ê
LÌ>ÊÞÊvÀÊv`°
/ iÊ>ÃÃV>ÌÊÜÌ ÊÀViÌÃÊ>ÃÊÃÌiiÀi`Ê
ÃÌÊÛÌ>Ê ÊÀiÃi>ÀV ÊvÀÊÌ iÊiÝÌÊxäÊ
Þi>ÀÃÊÌÜ>À`ÊÕ`iÀÃÌ>`}ÊÌ iÊiVÕi½ÃÊ
ÀiÊÊLiÊLÕ`}Ê>`Ê ÜÊÌÊ>VÌÃÊÊÌ iÊ
`iÞÃ]ÊÌiÃÌiÃÊ>`ÊÌ iÊÃiiÌÊÌÃivÊÌÊ
i«ÊVÌÀÊÌ iÊyÜÊvÊV>VÕÊÌÊ>`Ê
/ Ê , ]Ê
°
.OVEMBER
*!-%3
#2%$)40/24/
"Y ,UZ % 4AVERA -ENDOZA AND *OHN ( 7HITE
#2%$)4
W W W 3 C I ! M C O M
"*9,/ÊÓääÇÊ-
/ Ê , ]Ê
°
3#)%.4)&)# !-%2)#!.
+(
;4(% "!3)#3=
4(% -!+).' /& !. !#4)6% 6)4!-).
4HE TERM hVITAMIN $v REFERS TO TWO SLIGHTLY DIFFERENT MOLECULES $ MANUFACTURED BY HUMAN SKIN AND $ WHICH ORIGINATES IN PLANTS AND WHICH
PEOPLE CAN OBTAIN FROM FOOD "OTH VERSIONS OF $ MUST UNDERGO STAGES OF CONVERSION BY ENZYMES TO REACH A BIOLOGICALLY ACTIVE FORM KNOWN AS $
6)4!-). $ &2/- &//$
6)4!-). $ -!$% "9 (5-!. 3+).
5LTRAVIOLET
" LIGHT
IS
$
$
%PIDERM
56" LIGHT
DEHYDROCHOLESTEROL
6ITAMIN $ IS MADE BY SKIN CELLS CALLED KERATINOCYTES WHEN ULTRAVIOLET
L
" LIGHT AND HEAT ACT ON A BREAKDOWN PRODUCT OF CHOLESTEROL
$ERMIS
4O CIRCULATION
+ERATINOCYTES
-ELANOCYTE
,)6%2
$ OR $
DEHYDROCHOLESTEROL
6ITAMIN $ FOUND IN CERTAIN FOODS IS DERIVED
FROM A SIMILAR PLANT STEROL MOLECULE
7HETHER MANUFACTURED IN THE
SKIN OR INGESTED BOTH $ AND $ ENTER THE CIRCULATORY SYSTEM
%NZYME
7HEN CIRCULATING $ OR $ REACHES THE
L
LIVER IT IS CHEMICALLY CONVERTED BY ENZYMES
INTO HYDROXYVITAMIN $ $ 4HE $ FORM
OF THE VITAMIN THEN REENTERS THE CIRCULATION
,/#!, !#4)6!4)/.
3KIN IS THE ONLY TISSUE IN THE HUMAN BODY THAT CAN
MANUFACTURE $ AS WELL AS ALL THE ENZYMES NEEDED
TO CONVERT $ INTO $ AND THEN INTO $ )MMUNE
CELLS AND SEVERAL OTHER TISSUES CAN MAKE THE ENZYME
NEEDED TO CONVERT $ INTO $ LOCALLY
%NZYME
$
+)$.%9
4O CIRCULATION
%NZYME
$
%NZYME
$
$
-UCH OF THE BODYS CIRCULATING $
L
UNDERGOES A lNAL TRANSFORMATION IN THE
KIDNEYS WHERE ENZYMES CONVERT $ INTO
$ WHICH IS RELEASED TO THE CIRCULATION AND
TRAVELS TO THE MANY DIFFERENT ORGANS AND CELL
TYPES WHERE VITAMIN $ AFFECTS PHYSIOLOGY
ÕÌÊvÊLiÃÊvÀÊÌ iÊL`ÃÌÀi>°ÊÊÌ iÊ«>ÃÌÊ
µÕ>ÀÌiÀÊViÌÕÀÞ]Ê ÜiÛiÀ]ÊÃÌÕ`iÃÊvÊÛÌ>Ê ½ÃÊ
vÕVÌÊ >ÛiÊLÀ>`ii`]ÊÀiÛi>}ÊÌ >ÌÊÌ iÊÃ
V>i`ÊÃÕÃ iÊÛÌ>Ê`iÃÊv>ÀÊÀiÊÌ >ÊLÕ`Ê
LiÃ°Ê ÝÌiÃÛiÊiÛ`iViÊÜÊà ÜÃÊÌ >ÌÊ Ê >ÃÊ
«ÌiÌÊ>ÌV>ViÀÊ>VÌÃÊ>`Ê>ÃÊÃiÀÛiÃÊ>ÃÊ>Ê
«ÀÌ>ÌÊÀi}Õ>ÌÀÊvÊÕiÊÃÞÃÌiÊÀiëÃ
iðÊÀiÛiÀ]Ê>ÞÊvÊ ½ÃÊiÜÞÊÀiV}âi`ÊLi
iwÌÃÊ>ÀiÊ>Ýâi`ÊÜ iÊÌÊÃÊ«ÀiÃiÌÊÊÌ iÊ
L`ÃÌÀi>Ê>ÌÊiÛiÃÊVÃ`iÀ>LÞÊ } iÀÊÌ >Ê
Ì ÃiÊvÕ`ÊÊ>ÞÊ««Õ>ÌðÊ/ iÃiÊw`}Ã]Ê
Ì}iÌ iÀÊÜÌ Êi«`i}V>Ê`>Ì>Ê}ÊÜÊ
ÛÌ>Ê ÊiÛiÃÊÌÊ`Ãi>Ãi]ÊÃÕ««ÀÌÊÌ iÊ«ÃÃL
ÌÞÊÌ >ÌÊÜ`iëÀi>`ÊÛÌ>Ê Ê`iwViVÞÊÃÊV
ÌÀLÕÌ}ÊÌÊ>ÊÕLiÀÊvÊÃiÀÕÃÊiÃÃiðÊ
+) 3 # ) % . 4 ) & ) # ! - % 2 ) # ! .
"*9,/ÊÓääÇÊ-
4O CIRCULATION
! 6ERSATILE 3WITCH
/Ê>iÊÃiÃiÊvÊiÜÊw`}ÃÊ>LÕÌÊÛÌ>Ê ]Ê
ÌÊ«>ÞÃÊÌÊwÀÃÌÊÀiÛiÜÊÜ >ÌÊ Ê>VÌÕ>ÞÊÃÊ>`Ê ÜÊ
ÌÊÃÊÕÃi`ÊÊÌ iÊ Õ>ÊL`Þ°Ê*i«iÊV>ÊLÌ>Ê
Ì iÊiVÕiÊÜÊ>ÃÊÛÌ>Ê ÊvÀÊÌi`Ê
v`ÊÃÕÀViÃ]ÊÃÕV Ê>ÃÊv>ÌÌÞÊwà Ê>`Êwà Ê]Ê>`]Ê
Ì`>Þ]ÊvÀÊ`iÌ>ÀÞÊÃÕ««iiÌÃ°Ê ÕÌÊÜiÊV>Ê
>ÃÊ>iÊÌÊÕÀÃiÛiÃ]ÊÌ ÀÕ} Ê>ÊV iV>ÊÀi>V
ÌÊÌ >ÌÊ >««iÃÊÊÌ iÊÃÊÜ iÊÌÊÃÊiÝ«Ãi`Ê
ÌÊÕÌÀ>ÛiÌÊ Ê16 ®Ê} Ì°Ê-ÌÀVÌÞÊëi>}]Ê
Ì i]ÊÛÌ>Ê ÊÃÊÌÊ>ÊÛÌ>Ê>ÌÊ>]ÊLiV>ÕÃiÊ
ÜÌ Ê`iÀ>ÌiÊ16 ÊiÝ«ÃÕÀi]ÊÜiÊ`ÊÌÊii`Ê
ÌÊ}iÌÊÌÊvÀÊv`°ÊÊÌi«iÀ>ÌiÊÀi}ÃÊvÊÌ iÊ
ÜÀ`]Ê ÜiÛiÀ]Ê16 Ê} ÌÊÃÊÃÕvwViÌÊÌÊ
`ÕViÊ>`iµÕ>ÌiÊÛÌ>Ê ÊÃÞÌ iÃÃÊÊÌ iÊÃÊ
/ Ê , ]Ê
°
.OVEMBER
!.$2%7 37)&4
$
*!-%3 0/24/
vÀÊÕ«ÊÌÊÃÝÊÌ ÃÊvÊÌ iÊÞi>À]Ê>`ÊÌ iÊ`iÌ>ÀÞÊ
ÃÕÀViÃÊvÊÛÌ>Ê ÊLiViÊiÃÃiÌ>ÊQÃiiÊLÝÊ
Ê««ÃÌiÊ«>}iR°Ê
/ iÊÌiÀʺÛÌ>Ê »Ê}iiÀ>ÞÊÀiviÀÃÊViV
ÌÛiÞÊÌÊÌ iÊÌÜÊÛiÀÞÊÃ>ÀÊiVÕiÃÊÌ >ÌÊ
ViÊvÀÊi>V ÊvÊÌ ÃiÊÃÕÀViðÊ6Ì>Ê Î]Ê
Ü V ÊÃÊ>ÃÊÜÊ>ÃÊV iV>VviÀ]ÊÃÊVÀi>Ì
i`ÊLÞÊÃÊViÃÊV>i`ÊiÀ>ÌVÞÌiÃÊvÀÊ>Ê
LÀi>`ÜÊ«À`ÕVÌÊvÊV iÃÌiÀ]ÊÇ`i Þ`À
V iÃÌiÀ]ÊÊÀiëÃiÊÌÊ16 Ê} Ì°Ê6Ì>Ê
Ó ]ÊÀÊiÀ}V>VviÀ]ÊÃÊ`iÀÛi`ÊvÀÊ>ÊÃ>ÀÊ
«>ÌÊÃÌiÀ]Ê>`ÊÌ iÊÀiÃÕÌ}ÊiVÕiÊ >ÃÊ
Ã} ÌÊÃÌÀÕVÌÕÀ>Ê`vviÀiViÃÊÌ >ÌÊ`ÃÌ}ÕÃ ÊÌÊ
vÀÊ Î°Ê iÌ iÀÊÛiÀÃÊ >ÃÊ>ÞÊL}V>Ê>V
ÌÛÌÞÊÊÌ iÊL`Þ]Ê ÜiÛiÀ°ÊÀÃÌ]ÊiÌ iÀÊi
VÕiÊÕÃÌÊLiÊ`wi`ÊLÞÊ>ÊÃiÀiÃÊvÊÀi>Ìi`Êi
âÞiÃÊÊ>Ê«ÀViÃÃÊV>i`Ê Þ`ÀÝÞ>Ì]ÊÜ V Ê
>``ÃÊÌÜÊÌ À`ÃÊvÊ>ÊÜ>ÌiÀÊiVÕiÊÌÊ}iiÀ>ÌiÊ
Óx Þ`ÀÝÞÛÌ>Ê ÊÓx ®°Ê
/ >ÌÊVÛiÀÃÊÌ>iÃÊ«>ViÊ«À>ÀÞÊÊÌ iÊ
ÛiÀ]ÊLÕÌÊÛ>ÀÕÃÊViÊÌÞ«iÃÊÜÌ ÊÌ iÊÃÊ>ÀiÊ
>ÃÊV>«>LiÊvÊ«iÀvÀ}ÊÌ iÊÌÀ>ÃvÀ>ÌÊ
V>Þ°Ê/ iÊÓx Ê>`iÊLÞÊÌ iÊÛiÀÊÃÊiÌ iiÃÃÊ
Ì iÊ>ÀÊvÀÊvÊÛÌ>Ê ÊVÀVÕ>Ì}ÊÊÌ iÊ
L`ÃÌÀi>°Ê7 iÊÌÊÃÊii`i`ÊÊÌ iÊL`Þ]Ê>Êw
>ÊVÛiÀÃÊÌÊÌ iÊL}V>ÞÊ>VÌÛiÊvÀÊÃÊ
ÀiµÕÀi`p Óx ÊÃÊvÕÀÌ iÀÊ Þ`ÀÝÞ>Ìi`Ê>`ÊLi
ViÃÊ£]Óx` Þ`ÀÝÞÛÌ>Ê Ê£]Óx ®°Ê/ iÊ
iâÞiÊÌ >ÌÊ«iÀvÀÃÊÌ ÃÊÌ>Ã]Ê£>« > Þ`ÀÝ
Þ>Ãi]ÊÜ>ÃÊwÀÃÌÊ`ÃVÛiÀi`ÊÊÌ iÊ`iÞ]Ê>`ÊÀi
>Ê «ÀViÃÃ}Ê ÃÊ ÀiëÃLiÊ vÀÊ }iiÀ>Ì}Ê
ÕV ÊvÊÌ iÊL`Þ½ÃÊVÀVÕ>Ì}Ê£]Óx ÊÃÕ««Þ°Ê
"ViÊ>}>]Ê ÜiÛiÀ]ÊÃViÌÃÌÃÊÜÊÀi>âiÊ
Ì >ÌÊ>ÞÊÌ iÀÊÌÃÃÕiÃ]ÊVÕ`}ÊViÃÊvÊÌ iÊ
ÕiÊÃÞÃÌiÊ>`ÊÌ iÊÃ]ÊV>Ê>ÃÊ>iÊÌ >ÌÊ
iâÞiÊ>`Ê«iÀvÀÊÌ iÊÓx ÊVÛiÀÃÊÌ i
ÃiÛiðÊ-ÊÃÊÌ iÀivÀiÊÕµÕiÊ>}ÊÀ}>ÃÊÊ
Ì >ÌÊÌÊÃÊV>«>LiÊvÊ>Õv>VÌÕÀ}ÊL}V>ÞÊ
>VÌÛiÊ£]Óx ÊÊÌ iÊ«ÀiÃiViÊvÊ16 Ê} ÌÊvÀÊ
ÃÌ>ÀÌÊÌÊvà ]Ê>Ì Õ} ÊV>Ê«À`ÕVÌÊvÊ
£]Óx ÊvÀÊVÀVÕ>Ì}ÊÓx ÊÊÌ iÀÊÌÃÃÕiÃÊÃÊ>Ê
ÃÕLÃÌ>Ì>ÊÃÕÀViÊvÊÛÌ>Ê ½ÃÊL}V>Ê>V
ÌÛÌÞÊÊÌ iÊL`ÞÊÌ >ÌÊÜ>ÃÊÌÊ>««ÀiV>Ìi`ÊÕÌÊ
ÛiÀÞÊÀiViÌÞ°Ê"ViÊÌ iÊLÀi>`Ì ÊvÊ ½ÃÊ>VÌÛÌÞÊÃÊ
VÃ`iÀi`]ÊÌ Õ} ]ÊÌÊLiViÃÊi>ÃÞÊÌÊÃiiÊÜ ÞÊ
Ì iÊ>LÌÞÊÌÊ>iÊÌÃÊ>VÌÛiÊvÀÊvÀÊV>ÊÕÃiÊ
} ÌÊLiÊ«ÀÌ>ÌÊÌÊViÀÌ>ÊÌÞ«iÃÊvÊViðÊ
/ iÊ£]Óx ÊiVÕiÊvÕVÌÃÊ>ÃÊ>ÊÃÜÌV Ê
Ì >ÌÊV>ÊÌÕÀÊ}iiÃʺ»ÊÀʺvv»ÊÊÛÀÌÕ>ÞÊ
iÛiÀÞÊÌÃÃÕiÊÊÌ iÊ Õ>ÊL`Þ°Ê/ ÃÊvÀÊvÊ Ê
>VÌÃÊLÞÊ>ÌÌ>V }ÊÌÊ>Ê«ÀÌiÊÜÊ>ÃÊÌ iÊÛ
Ì>Ê ÊÀiVi«ÌÀÊ6 ,®]ÊÜ V ÊÃiÀÛiÃÊ>ÃÊ>ÊÃ
V>i`ÊÌÀ>ÃVÀ«ÌÊv>VÌÀÊÃ`iÊ>ÊVi½ÃÊÕViÕðÊ
"ViÊLÕ`ÊLÞÊ£]Óx ]ÊÌ iÊ6 ,Ê«ÀÌiÊÃiiÃÊ
ÕÌÊ>ÊV«>Ê«ÀÌi]ÊÌ iÊÀiÌ`ÝÊÀiVi«
W W W 3 C I ! M C O M
ÌÀÊ,8,®]Ê>`ÊÌ iÊV«iÝÊÌ iÞÊvÀÊL`ÃÊÌÊ
>ÊëiVwVÊÀi}ÊvÊÌ iÊVi½ÃÊ
Ê>`>ViÌÊÌÊ>Ê
Ì>À}iÌÊ}ii°Ê/ iÀÊ>ÌÌ>V iÌÊÌÊÌ iÊ
Ê
`ÕViÃÊViÕ>ÀÊ>V iÀÞÊÌÊLi}ÊÌÀ>ÃVÀL}Ê
Ì iÊi>ÀLÞÊ}iiÊÌÊ>ÊvÀÊÌ >ÌÊÌ iÊViÊÜÊ
ÌÀ>Ã>ÌiÊÌÊ>Ê«ÀÌiÊQÃiiÊLÝÊÊ«>}iÊÈnR°Ê
ÞÊV>ÕÃ}Ê>ÊViÊÌÊ>iÊ>Ê«>ÀÌVÕ>ÀÊ«ÀÌi]Ê
£]Óx Ê>ÌiÀÃÊViÕ>ÀÊvÕVÌ]Ê>`ÊÌ ÃÊ>LÌÞÊ
ÌÊÌÀ}}iÀÊ}iiÊ>VÌÛÌÞÊÊ`vviÀiÌÊViÃÊÃÊÌ iÊ
L>ÃÃÊvÊÛÌ>Ê ½ÃÊÜ`iëÀi>`Ê« ÞÃ}V>Ê
ivviVÌÃ°Ê iV>ÕÃiÊ ÊÃÊ>ÊÃÕLÃÌ>ViÊ>Õv>VÌÕÀi`Ê
ÊiÊÌÃÃÕiÊ>`ÊVÀVÕ>ÌiÃÊÌ ÀÕ} ÊÌ iÊL`ÞÊ
yÕiV}Ê>ÞÊÌ iÀÊÌÃÃÕiÃ]ÊÌÊÃÊ>ÃÊÌiV
V>ÞÊ>Ê Ài°ÊÊv>VÌ]ÊÌ iÊ6 ,ÊLi}ÃÊÌÊ>Ê
v>ÞÊvÊ«ÀÌiÃÊÜÊ>ÃÊÕVi>ÀÊÀiVi«ÌÀÃÊ
Ì >ÌÊÀië`ÊÌÊ«ÜiÀvÕÊÃÌiÀ`>Ê ÀiÃÊ
ÃÕV Ê>ÃÊiÃÌÀ}iÊ>`ÊÌiÃÌÃÌiÀi°
ÌÊi>ÃÌÊ£]äääÊ`vviÀiÌÊ}iiÃÊ>ÀiÊLiiÛi`ÊÌÊ
LiÊÀi}Õ>Ìi`ÊLÞÊ£]Óx ]ÊVÕ`}ÊÃiÛiÀ>Ê
ÛÛi`ÊÊÌ iÊL`Þ½ÃÊV>VÕÊ«ÀViÃÃ}ÊÌ >ÌÊ>V
VÕÌÊvÀÊ ½ÃÊÜiÜÊÀiÊÊLiÊvÀ>
3/52#%3 /&
Ì°Ê"ÛiÀÊÌ iÊ«>ÃÌÊÌÜÊ`iV>`iÃ]Ê ÜiÛiÀ]ÊÃV
6)4!-).
$
iÌÃÌÃÊ >ÛiÊ `iÌvi`Ê >ÞÊ Ì iÀÊ }iiÃÊ
yÕiVi`ÊLÞÊÛÌ>Ê Ê>VÌÛÌÞÊÊÌ iÊL`Þ]Ê 6ITAMINS $ AND $ OCCUR NATURAL
VÕ`}Ê}iiÃÊÜÌ ÊVÀÌV>ÊÀiÃÊÊ>ÊÛ>ÀiÌÞÊvÊ LY IN SOME FOODS AND BOTH VER
SIONS OF THE VITAMIN ARE ADDED TO
ViÕ>ÀÊ`iviÃiðÊ
&ORTIFICATION BY $
-ViÊÌ iÊ£näÃÊÛ>ÀÕÃÊiÃÊvÊiÛ`iViÊ >ÛiÊ
«Ìi`ÊÌÊÛÌ>Ê ½ÃÊ«ÀÌiVÌÛiÊivviVÌÊ>}>ÃÌÊ
V>ViÀ°Ê >ÞÊ i«`i}V>Ê ÃÌÕ`iÃÊ >ÛiÊ
à ÜÊ>ÊÃÌÀ}ÊÛiÀÃiÊÀi>ÌÊLiÌÜiiÊiÝ«
ÃÕÀiÊÌÊÃÕ} ÌÊ>`ÊÌ iÊV`iViÊvÊViÀÌ>Ê
ÌÞ«iÃÊvÊV>ViÀ°Ê-ÌÕ`iÃÊÊ>>ÃÊ>`ÊViÊVÕ
ÌÕÀiÃÊ >ÛiÊÃÕ««ÀÌi`ÊÌ >ÌÊ>ÃÃV>ÌÊ>`Ê i«i`Ê
ÌÊ ««ÌÊ Ì iÊ iV >ÃÃÊ Ì >ÌÊ >ÞÊ LiÊ
ÛÛi`°Ê
Ê>ÊÕÃiÊ`iÊvÊ i>`Ê>`ÊiVÊV>ViÀ]Ê
vÀÊiÝ>«i]Ê>ÊV«Õ`ÊV>i`Ê £än]ÊÜ V Ê
ÃÊ>ÊÃÞÌ iÌVÊ>>}ÕiÊvÊ£]Óx ]ÊÀi`ÕVi`ÊÌÕÀÊ
}ÀÜÌ ÊLÞÊnäÊ«iÀViÌ°Ê->ÀÊÀiÃÕÌÃÊ >ÛiÊLiiÊ
>ÌÌ>i`ÊÊ>>Ê`iÃÊvÊLÀi>ÃÌÊ>`Ê«ÀÃÌ>ÌiÊ
V>ViÀ°Ê`iÌvÞ}ÊÌ iÊ}iiÃÊ>VÌÛ>Ìi`ÊLÞÊÌ ÃÊ
ÃÞÌ iÌVÊÛiÀÃÊvÊ Ê >ÃÊ i«i`ÊiÝ
«>ÊÌ iÃiÊÀiëÃiðÊ1VÌÀi`Ê
«ÀviÀ>Ì]ÊÀÊ}ÀÜÌ ]ÊÃÊ>Ê >
>ÀÊvÊÌÕÀÊViÃ]Ê>`Ê £änÊ
Ü>ÃÊà ÜÊÌÊÃÕ««ÀiÃÃÊÌ iÊViýÊ
>LÌÞÊÌÊÕÌ«ÞÊLÞÊ>ÌiÀ}ÊÌ iÊ
>VÌÛÌÞÊ vÊ >Ê ÕLiÀÊ vÊ `vviÀiÌÊ
}iiðÊ"iÊ}iiÊÀ>«i`ÊÕ«ÊLÞÊÌ iÊV«Õ` p
{xAp ÃÊ ÜiÊ ÜÊ vÀÊ ÌÀ}}iÀ}Ê
}ÀÜÌ Ê>ÀÀiÃÌÊÊÀ>ÊViÃÊÜ ÃiÊ
ÊÃÊ
`>>}i`]ÊÌ iÀiLÞÊÀi`ÕV}ÊÌ iÀÊÀÃÊvÀÊLiV
}ÊV>ViÀÕðÊÊ>``Ì]Ê £änÊ>VÌÛ>ÌiÃÊ
"*9,/ÊÓääÇÊ-
/ Ê , ]Ê
°
CERTAIN hFORTIlEDv PRODUCTS
&OODS PROVIDE RELATIVELY SMALL
DOSES OF $ COMPARED WITH
AMOUNTS MADE BY THE SKIN IN
RESPONSE TO 56" LIGHT
)5 INTERNATIONAL UNITS
#OD LIVER OIL TBSP
)5 $
#OOKED TUNA
SARDINES
MACKEREL OR
SALMON n OZ
n )5 $
3HIITAKE MUSHROOMS
FRESH OZ
)5 $
DRIED OZ
)5 $
%GG YOLK
)5 $ OR $
&ORTIlED DAIRY PRODUCTS
ORANGE JUICE OR
CEREALS ONE SERVING
n )5 $ OR $
&ULL BODY EXPOSURE TO 56"
TO MINUTES AT MIDDAY IN
SUMMER FAIR SKIN
)5 $
3#)%.4)&)# !-%2)#!.
+*
;$ ). !#4)/.=
! "2/!$ !#4).' '%.% 37)4#(
4HE BIOLOGICALLY ACTIVE FORM OF VITAMIN $ $ TURNS hONv CERTAIN GENES LEADING TO THE
MANUFACTURE OF THE PROTEINS THEY ENCODE 4HOSE PROTEINS MAY HAVE LOCAL OR WIDESPREAD
PHYSIOLOGICAL EFFECTS -ORE THAN DIFFERENT GENES IN AT LEAST A DOZEN TISSUES AND CELL
TYPES THROUGHOUT THE BODY ARE THOUGHT TO BE REGULATED BY $
#ELL NUCLEUS
)NSIDE A CELL NUCLEUS THE $ MOLECULE BINDS TO A PROTEIN CALLED THE VITAMIN $ RECEPTOR 6$2
L
$
6ITAMIN $
RESPONSE
ELEMENT
6$2
4HE 6$2 THEN FORMS A COMPLEX WITH A SIMILAR PROTEIN THE
L
RETINOID X RECEPTOR 282 AND TOGETHER THE DUO BINDS TO A REGION
IN THE $.! STRAND KNOWN AS A VITAMIN $ RESPONSE ELEMENT
4RANSCRIPTION
FACTORS
282
'ENE
6$2 282 BINDING TO THE RESPONSE ELEMENT
L
RECRUITS TRANSCRIPTION FACTOR PROTEINS TO THE COMPLEX
LEADING TO TRANSCRIPTION OF THE NEARBY GENE
'ENE TRANSCRIPT
4HE GENE TRANSCRIPT THEN LEAVES THE NUCLEUS TO BE TRANSLATED
L
BY CELLULAR MACHINERY IN THE CYTOPLASM INTO A lNISHED PROTEIN
4)335%3
!&&%#4%$ "9
6)4!-). $
4HE 6$2 RECEPTOR PROTEIN
IS FOUND IN MANY BODY
TISSUES AS WELL AS CIRCULATING
IMMUNE CELLS INDICATING A ROLE
FOR ACTIVE VITAMIN $ IN
REGULATING GENE ACTIVITY IN
THOSE LOCATIONS 4HE LIST BELOW
INCLUDES SOME OF THE TISSUES AND
CELLS WHERE $ ACTION HAS
BEEN ESTABLISHED
"ONE
"RAIN
"REAST
&AT
)NTESTINE
)MMUNE CELLS
+IDNEYS
,IVER
.ERVES
0ANCREAS
0ARATHYROID
GLAND
0ROSTATE
3KIN
KERATINOCYTES
+- 3 # ) % . 4 ) & ) # ! - % 2 ) # ! .
}iiÃÊÌ >ÌÊ`ÀiVÌÊÌÕÀÊViÃÊÌÊLiViÊÀiÊ`v
viÀiÌ>Ìi`]Ê>Ê>ÌÕÀiÊÃÌ>ÌiÊÌ >ÌÊÌÃÊ>ÊVi½ÃÊ
>LÌÞÊÌÊ«ÀviÀ>Ìi°Ê
Ì iÀÊ`âiÊ}iiÃÊÛÛi`ÊÊ>ÊVi½ÃÊi
iÀ}ÞÊ>>}iiÌÊ>`ÊÃiv`iÌÝwV>ÌÊ >ÛiÊ
>ÃÊLiiÊi`ÊÌÊ £än½ÃÊ>ÌÌÕÀÊ>VÌðÊ
/ >ÌÊiÝ«iÀiÌ>ÊV«Õ`]ÊÜ V ÊÜ>ÃÊV i
V>ÞÊ`iÃ}i`ÊÌÊ >ÛiÊ£]Óx iÊ>VÌÛÌÞÊÜÌ
ÕÌÊV>ÕÃ}ÊÌÝVÊiÛiÃÊvÊV>VÕÊÌÊLÕ`ÊÕ«Ê
ÊÌ iÊL`ÃÌÀi>Ê>`ÊL`ÞÊÌÃÃÕiÃ]ÊÃÊiÊvÊ
ÃiÛiÀ>Ê«ÌiÌ>ÊV>ViÀÊÌ iÀ>«iÃÊ`iÛi«i`ÊLÞÊ
« >À>ViÕÌV>ÊV«>iÃÊÌÊ >ÀiÃÃÊÛÌ>Ê
½ÃÊ«ÜiÀvÕÊ>ÌÌÕÀÊ«À«iÀÌiðÊ
`ii`]ÊÕÀÊ>LÀ>ÌÀÞÊ}ÀÕ«Ê>ÌÊVÊ1
ÛiÀÃÌÞÊÜ>ÃÊ>ÃÊÛiÃÌ}>Ì}Ê ½ÃÊV>ViÀÀi>Ìi`Ê
>VÌÃÊÊÓää{ÊÜ iÊÜiÊ>`ÛiÀÌiÌÞÊ ÌÊÊ>Ê
V«iÌiÞÊ`vviÀiÌÊvÀÊvÊ« ÞÃ}V>Ê`i
viÃiÊ}ÛiÀi`ÊLÞÊ£]Óx °Ê>ÞÊvÊÌ iÊ}iiÃÊ
Ài}Õ>Ìi`ÊLÞÊÛÌ>Ê Ê >ÛiÊLiiÊ`ÃVÛiÀi`ÊÊ
ÀiViÌÊÞi>ÀÃÊLÞÊÃViÌÃÌÃÊÃV>}Ê«>ÀÌÃÊvÊÌ iÊ
Õ>Ê}ii]Ê}ÊvÀÊÛÌ>Ê ÊÀiëÃiÊ
iiiÌÃÊ6 , î p Ì iÊ`ÃÌVÌÛiÊÃiµÕiViÃÊ
vÊ
ÊV`iÊÌ >ÌÊiÊ>`>ViÌÊÌÊ}iiÃ]ÊÌÊÜ V Ê
Ì iÊ6 ,,8,Ê«ÀÌiÊV«iÝÊL`ðÊÊV
"*9,/ÊÓääÇÊ-
>LÀ>ÌÊÜÌ Ê-ÞÛiÊ>`iÀÊvÊÌ iÊ1ÛiÀÃÌÞÊ
vÊÌÀi>]ÊÜiÊÕÃi`Ê>ÊV«ÕÌiÀÊ>}ÀÌ Ê`i
Ã}i`ÊÌÊÃV>ÊÌ iÊiÌÀiÊ}ii]ÊÃii}ÊÕÌÊ
6 , ÃÊ>`Ê>««}ÊÌ iÀÊ«ÃÌÃÊÀi>ÌÛiÊÌÊ
i>ÀLÞÊ}iiðÊ
Ì Õ} ÊÌ iÃiÊ>««}ÊÃÌÕ`iÃÊ``Ê i«ÊÕÃÊ
ÌÊLiÌÌiÀÊÕ`iÀÃÌ>`ÊÃiÊvÊÌ iÊ>ÌV>ViÀÊ>V
ÌÃÊvÊÛÌ>Ê ]ÊÌ iÞÊ>ÃÊÀiÛi>i`Ê6 , ÃÊ
Þ}ÊVÃiÊÌÊÌÜÊ}iiÃÊÌ >ÌÊiV`iÊ>ÌVÀ
L>Ê«i«Ì`iÃÊV>i`ÊV>Ì iV`Ê>`Ê`iviÃÊ
LiÌ>ÊÓ°Ê/ iÃiÊÃ>Ê«ÀÌiÃÊ>VÌÊ>ÃÊ>ÌÕÀ>Ê>Ì
LÌVÃÊ>}>ÃÌÊ>ÊÜ`iÊëiVÌÀÕÊvÊL>VÌiÀ>]ÊÛ
ÀÕÃiÃÊ>`ÊvÕ}°Ê7iÊ«ÕÀÃÕi`ÊÌ ÃÊi>`ÊÜÌ ÊÃÌÕ`
iÃÊÊVÕÌÕÀi`Ê Õ>ÊViÃÊ>`ÊvÕ`ÊÌ >ÌÊiÝ
«ÃÕÀiÊÌÊ£]Óx ÊV>ÕÃi`Ê>ÊÀi>ÌÛiÞÊ`iÃÌÊ
VÀi>ÃiÊÊÌ iÊViýÊ>Õv>VÌÕÀiÊvÊÌ iÊ`ivi
ÃÊLiÌ>ÊÓÊ«i«Ì`i°Ê ÕÌÊÊ>ÊÕLiÀÊvÊ`vviÀiÌÊ
ViÊÌÞ«ià p VÕ`}ÊÕiÊÃÞÃÌiÊViÃÊ>`Ê
iÀ>ÌVÞÌià p Ì iÊÀÃiÊÊV>Ì iV`Ê«À`ÕV
ÌÊÜ>ÃÊ`À>>ÌV°Ê7iÊiÝÌÊ`iÃÌÀ>Ìi`ÊÌ >ÌÊ
ÕiÊ ViÃÊ ÌÀi>Ìi`Ê ÜÌ Ê £]Óx ]Ê Ü iÊ iÝ
«Ãi`ÊÌÊ«>Ì }iVÊL>VÌiÀ>]ÊÀii>Ãi`Êv>VÌÀÃ p
«ÀiÃÕ>LÞÊV>Ì iV` p Ì >ÌÊi`ÊvvÊÌ iÊ
L>VÌiÀ>°
/ Ê , ]Ê
°
.OVEMBER
!.$2%7 37)&4
&INISHED
PROTEIN
,5#9 2%!$).' )++!.$!
!.! 0!,)*!.
* «ÊÕÊ>`Ê,LiÀÌÊ`ÊvÊÌ iÊ1ÛiÀ
ÃÌÞÊvÊ >vÀ>]ÊÃÊ}iiÃ]Ê>`ÊÌ iÀÊV
>LÀ>ÌÀÃÊÃÕLÃÌ>Ì>ÞÊ>`Û>Vi`ÊÌ ÃÊiÊvÊ
ÛiÃÌ}>ÌÊ>ÃÌÊÞi>ÀÊLÞÊÃ Ü}ÊÌ >ÌÊ Õ>Ê
ÕiÊViÃÊÀië`ÊÌÊL>VÌiÀ>ÊViÊÜ>ÃÊLÞÊ
>Õv>VÌÕÀ}ÊLÌ Ê6 ,Ê«ÀÌiÃÊ>`ÊÌ iÊi
âÞiÊÌ >ÌÊVÛiÀÌÃÊVÀVÕ>Ì}ÊÓx ÊÌÊÌ iÊL
}V>ÞÊ>VÌÛiÊ£]Óx °ÊÊÌ iÊ}ÀÕ«½ÃÊiÝ«iÀ
iÌÃ]ÊÌ iÃiÊiÛiÌÃÊ`ÕVi`ÊÌ iÊÕiÊViÃÊÌÊ
ÃÌ>ÀÌÊ«À`ÕV}ÊV>Ì iV`Ê>`ÊÌÊ`iÃÌÀ>ÌiÊ
>ÌVÀL>Ê>VÌÛÌÞÊ>}>ÃÌÊ>ÊÛ>ÀiÌÞÊvÊL>V
ÌiÀ>]ÊVÕ`}ÊiÊÌ >ÌÊÃÊ«iÀ >«ÃÊÌ iÊÃÌÊ
ÌÀ}Õ}\ÊÞVL>VÌiÀÕÊÌÕLiÀVÕÃðÊ/ ÕÃ]Ê
vÀÊÌ iÊwÀÃÌÊÌi]ÊÌ iÊ}ÀÕ«ÊÀiÛi>i`Ê>Ê«>ÕÃLiÊ
L>ÃÃÊvÀÊÌ iÊÞÃÌiÀÕÃÊivwV>VÞÊvÊÌ iÊÌÕLiÀVÕ
ÃÃÊÃÕÃ iÊVÕÀi\ÊÌ iÊÃÕÃ>i`ÊVÛ>iÃ
ViÌýÊÛÌ>Ê ÊLÃÌÊVÕ`Ê >ÛiÊ«ÀÛ`i`Ê
Ì iÀÊÕiÊViÃÊÜÌ ÊÌ iÊÀ>ÜÊ>ÌiÀ>Êii`
i`ÊÌÊ}iiÀ>ÌiÊ>Ê>ÌÕÀ>Ê>ÌLÌVÊÌ >ÌÊvÕ} ÌÊ
vvÊÌ iÊ/ ÊL>VÌiÀ>°Ê
ÃÊ}>«ÃÊÊÕÀÊÕ`iÀÃÌ>`}ÊvÊÛÌ>Ê Ê
« ÞÃ}ÞÊ>ÀiÊwi`Ê]ÊÀiÃi>ÀV iÀÃÊ >ÛiÊViÊ
ÌÊ>««ÀiV>ÌiÊÌ >ÌÊ>ÊÕLiÀÊvÊ ½ÃÊ«ÀÌiVÌÛiÊ>V
ÌÃÊÊÌ iÊL`ÞÊ} ÌÊ >ÛiÊiÛÛi`ÊvÀÊvÕV
ÌÃÊÀ}>Ì}Ê>ÌÊÌ iÊiVÕi½ÃÊÃÕÀVi]ÊÊÌ iÊ
ðÊ/ iÊ}ÀÜÌ >ÀÀiÃÌ}ÊyÕiViÊvÊ£]Óx Ê
ÊV>ViÀÊViÃÊ>iÃÊÃiÃiÊÊÌ ÃÊ} ÌÊLiV>ÕÃiÊ
iÝViÃÃÊ16 ÊiÝ«ÃÕÀiÊÃÊÜÊÌÊ`>>}iÊÌ iÊ
ÊvÊÃÊViÃ]ÊÜ V ÊV>Êi>`ÊÌ iÊÌÊLi
ViÊV>ViÀÕðÊ-iÊ >ÛiÊ>ÃÊëiVÕ>Ìi`Ê
Ì >ÌÊÌ iÊ>ÌVÀL>ÊÀiëÃiÊÀi}Õ>Ìi`ÊLÞÊÛ
Ì>Ê Ê ÃÊ >Ê >`>«Ì>ÌÊ Ì >ÌÊ } ÌÊ >ÛiÊ
iÛÛi`ÊÌÊV«iÃ>ÌiÊvÀÊ ½ÃÊÀiÊÊÃÕ««ÀiÃÃ
}ÊViÀÌ>ÊÌ iÀÊÕiÊÃÞÃÌiÊÀi>VÌÃ p
ëiVwV>Þ]ÊÌ ÃiÊÌ >ÌÊi>`ÊÌÊiÝViÃÃÛiÊy>
>Ì°ÊÃÊ>ÞÊvÊÕÃÊÜÊÌÊÜiÊvÀÊiÝ«i
ÀiVi]ÊiÝViÃÃÛiÊ16 ÊiÝ«ÃÕÀiÊV>ÕÃiÃÊÃÕLÕÀi`Ê
Ã]ÊÜ V Ê>ÌÊÌ iÊÌÃÃÕiÊiÛiÊÀiÃÕÌÃÊÊyÕ`Ê
LÕ`Õ«Ê>`Êy>>Ì°ÊÌ Õ} Ê>ÊÌi`Ê
>ÕÌÊvÊy>>ÌÊÃÊ>ÊLiiwV>ÊiV >
ÃÊvÀÊÜÕ`Ê i>}Ê>`Ê i«ÃÊÌ iÊÕiÊ
ÃÞÃÌiÊw} ÌÊvvÊviVÌ]ÊÌÊÕV Êy>>
ÌÊV>ÕÃiÃÊÌÃÊÜÊ >ÛV°Ê
*iÀ >«ÃÊÌÊÃÕÀ«ÀÃ}Þ]ÊÌ i]Ê>Ê«ÀiÃÃÛiÊ
L`ÞÊvÊÜÀÊÜÊÃ ÜÃÊÌ >ÌÊ£]Óx Ê>ÃÊ>VÌÃÊ
>ÃÊ>Ê>Ìy>>ÌÀÞÊ>}iÌÊÌ >ÌÊvÕVÌÃÊLÞÊ
yÕiV}ÊÕiÊViÊÌiÀ>VÌðÊÀÊiÝ>
«i]Ê`vviÀiÌÊÃÕLÌÞ«iÃÊvÊÕiÊViÃÊVÕ
V>ÌiÊLÞÊÃiVÀiÌ}Êv>VÌÀÃÊV>i`ÊVÞÌiÃÊÌÊ
Ì>ÌiÊ>Ê«>ÀÌVÕ>ÀÊÌÞ«iÊvÊÕiÊÀiëÃi°Ê
6Ì>Ê Ê >ÃÊLiiÊÃ ÜÊÌÊÀi«ÀiÃÃÊiÝ>}}iÀ
>Ìi`Êy>>ÌÀÞÊÀiëÃiÃÊLÞÊ LÌ}ÊÌ >ÌÊ
VÞÌiÊVÀÃÃÊÌ>°Ê
ÀiVÌÊiÛ`iViÊvÊÛÌ>Ê ½ÃÊ>ÌÕÀ>ÊÀiÊÊ
«ÀiÛiÌ}Êy>>ÌÊV>iÊwÀÃÌÊvÀÊ>>Ê
W W W 3 C I ! M C O M
iÝ«iÀiÌÃÊÊÌ iÊi>ÀÞÊ£äÃ]ÊÜ V Êà Üi`Ê
Ì >ÌÊViÊÌÀi>Ìi`ÊÜÌ Ê£]Óx ÊÜiÀiÊ«ÀÌiVÌi`Ê
vÀÊÌ iÊy>>ÌÊÀ>ÞÊ>ÃÃV>Ìi`ÊÜÌ Ê
ÜÕ`ÃÊ>`ÊÌ iÊV iV>ÊÀÀÌ>ÌÊ`ÌÀLi
âii]ÊÜ iÀi>ÃÊÛÌ>Ê q`iwViÌÊViÊÜiÀiÊ
Þ«iÀÃiÃÌÛiÊÌÊÌ ÃiÊÃ>iÊÃÕÌðÊ/ ÃÊ
ÕiÃÕ««ÀiÃÃ}ÊvÕVÌÊvÊÛÌ>Ê Êi
`>ÌiÞÊÃÕ}}iÃÌi`Ê>ÊÀ>}iÊvÊiÜÊÌ iÀ>«iÕÌVÊ
«ÃÃLÌiÃÊvÀÊÕÃ}ÊÛÌ>Ê ÊÀÊÌÃÊ>>}ÕiÃÊ
ÊÌ iÊVÌÀÊvÊ>ÕÌÕiÊ`Ãi>ÃiÃÊÌ Õ} ÌÊ
ÌÊLiÊV>ÕÃi`ÊLÞÊÛiÀ>VÌÛiÊVÞÌiÊÀiëÃiÃ]Ê
ÃÕV Ê>ÃÊ>ÕÌÕiÊ`>LiÌiÃ]ÊÕÌ«iÊÃViÀÃÃÊ
-®Ê>`Êy>>ÌÀÞÊLÜiÊ`Ãi>Ãi°
-ViÊÌ >ÌÊÌi]ÊÃViÌÃÌÃÊ >ÛiÊÀi>âi`ÊÌ >ÌÊ
>ÞÊViÊÌÞ«iÃ]ÊVÕ`}ÊÕiÊViÃ]Ê>ÀiÊV>
«>LiÊvÊÕÃ}ÊVÀVÕ>Ì}Ê£]Óx Ê>`ÊvÊVÛiÀÌ
}ÊVÀVÕ>Ì}ÊÓx ÊÌÊÌ iÊ>VÌÛiÊvÀÊvÊÌ iÊÛ
Ì>]ÊVwÀ}ÊÌ >ÌÊÌ iÊ>Ìy>>ÌÀÞÊ
>VÌÃÊvÊ£]Óx Ê>ÀiÊÌÊÀiÃÌÀVÌi`ÊÌÊÃÊViÃÊ
ÀÊëÞÊÌÊÌ iÊVÌiÝÌÊvÊÃÕLÕÀ°Ê
%PIDEMIC $EFICIENCY
,iV}ÌÊÌ >ÌÊ£]Óx Ê >ÃÊ>ÊLÀ>`ÊÀ>}iÊvÊ
L}V>Ê>VÌÛÌiÃÊv>ÀÊLiÞ`ÊÌÃÊÀiÊÊV>V
ÕÊ iÃÌ>ÃÃÊ >ÃÊÌ ÀÜÊÌÊÃ >À«ÊÀiivÊ>Ê
>À}iÊL`ÞÊvÊi«`i}V>ÊiÛ`iViÊÌ >ÌÊÜÊ
ÛÌ>Ê ÊiÛiÃÊVÀÀi>ÌiÊÃÌÀ}ÞÊÜÌ ÊViÀÌ>Ê
ÌÞ«iÃÊvÊ`Ãi>Ãi]Ê>}ÊÌ iÊV>ViÀÃ]Ê>ÕÌ
ÕiÊV`ÌÃÊ>`ÊiÛiÊviVÌÕÃÊ`Ãi>ÃiÃ]Ê
ÃÕV Ê>ÃÊyÕiâ>]Ê>ÃÊÜiÊ>ÃÊÜÌ ÊÃi>Ã>ÊÛ>À
>ÌÃÊÊiÃÃÊÀ>ÌiðÊÊ>``Ì]Ê>ÞÊvÊÌ iÊ
Ìi`Ê« ÞÃ}V>ÊÀiëÃiÃÊÌÊÛÌ>Ê ÊÃiiÊ
LÌ ÊÊÌ iÊ>LÀ>ÌÀÞÊ>`ÊÊVV>ÊÃÌÕ`iÃÊ>ÀiÊ
«Ìâi`Ê ÞÊ Ü iÊ VÀVÕ>Ì}Ê VViÌÀ>
ÌÃÊvÊÓx Ê>ÀiÊ } iÀÊÌ >ÊÃÊÌÞ«V>ÊÊ>ÞÊ
««Õ>ÌðÊiLiÀÃÊvÊÌ iÊÛÌ>Ê ÊÀiÃi>ÀV Ê
VÕÌÞÊ>ÀiÊÌ iÀivÀiÊV}ÊÌÊ>ÊÜ`i
ëÀi>`ÊVÃiÃÕÃÊÌ >ÌÊÃÕLÃÌ>Ì>ÊÕLiÀÃÊvÊ
«i«iÊÊÌi«iÀ>ÌiÊÀi}ÃÊvÊÌ iÊÜÀ`Ê >ÛiÊ
(/7 -5#( $
)3 $%3)2!",%
%STIMATES OF VITAMIN $ AVAILABLE TO THE
BODY ARE BASED ON MEASUREMENTS OF
$ CONCENTRATIONS IN BLOOD SERUM
,EVELS BETWEEN AND NANOGRAMS
PER MILLILITER OF SERUM ARE CONSIDERED
MINIMALLY SUFlCIENT FOR BONE HEALTH
ALTHOUGH SOME BENElCIAL CELLULAR
RESPONSES TO $ ARE OPTIMIZED AT HIGHER
CONCENTRATIONS "ELOW NGML HEALTH
RISKS INCREASE ABOVE NGML EXCESS
CALCIUM BUILDUP IN BLOOD AND TISSUES
AND SYMPTOMS OF TOXICITY ARE POSSIBLE
"*9,/ÊÓääÇÊ-
/ Ê , ]Ê
;4(% !54(/23=
,UZ % 4AVERA -ENDOZA AND *OHN
( 7HITE WORKED TOGETHER IN
7HITES LABORATORY AT -C'ILL 5NI
VERSITY INVESTIGATING THE MOLECULAR
ACTIVITIES OF VITAMIN $ IN HUMAN
CELLS 4HEY HAVE UNCOVERED ASPECTS
OF THE VITAMINS ROLE IN CANCER PRE
VENTION AND DISCOVERED WITH THEIR
COLLABORATORS THAT $ REGULATES CER
TAIN GENES INVOLVED IN CELL RESPONS
ES TO MICROBIAL INVADERS 4AVERA
-ENDOZA IS NOW A POSTDOCTORAL
FELLOW AT (ARVARD -EDICAL 3CHOOL
STUDYING VITAMIN $ AND BREAST CAN
CER (AVING WITNESSED VITAMIN $S
HEALTH PROTECTING ACTIONS lRST
HAND IN THE LAB BOTH AUTHORS TAKE
SUPPLEMENTS DURING THE PARTS OF
THE YEAR WHEN SUNLIGHT IS TOO WEAK
IN THE NORTHERN CITIES WHERE THEY
RESIDE TO PRODUCE ADEQUATE
AMOUNTS IN SKIN 7HITE TAKES
INTERNATIONAL UNITS OF $
DAILY DURING THOSE hVITAMIN $ WIN
TERv MONTHS AND 4AVERA -ENDOZA
TAKES
!BOVE NG
4OXICITY SYMPTOMS AND HYPERCALCEMIA
n NG 02%&%22%$ 2!.'%
n NG ).35&&)#)%.4
#ALCIUM ABSORPTION IMPAIRED
n NG $%&)#)%.4
2ICKETS SYMPTOMS MAY APPEAR
#ANCER RISKS RISE
!NTIMICROBIAL PEPTIDE RESPONSE
MAY BE INHIBITED
3ERUM $
NGML
°
3#)%.4)&)# !-%2)#!.
+.
,% 3 # ) % . 4 ) & ) # ! - % 2 ) # ! .
$ -!+%3 !
$)&&%2%.#%
'ROWING EVIDENCE SUGGESTS THAT
CHRONICALLY LOW LEVELS OF VITAMIN
$ RAISE A PERSONS RISK FOR CERTAIN
MAJOR ILLNESSES %XAMPLES OF lND
INGS BASED ON A POPULATIONS
BLOOD SERUM $ LEVELS OR 56 EXPO
SURE INCLUDE
N
TO HIGHER RISK FOR BREAST
PROSTATE AND COLON CANCERS AT
SERUM $ LEVELS BELOW NGML
N
&IVE TIMES HIGHER RISK OF OVARIAN
CANCER AMONG WOMEN LIVING AT
HIGH LATITUDES FOR EXAMPLE
.ORWAY AND )CELAND THAN WOMEN
LIVING AT EQUATORIAL REGIONS
N
LOWER RISK FOR ALL CANCERS
AMONG .EBRASKA WOMEN AGE
AND OLDER TAKING )5 OF $
DAILY OVER A THREE YEAR PERIOD
COMPARED WITH A PLACEBO GROUP
N
LOWER RISK FOR MULTIPLE
SCLEROSIS AT SERUM $ LEVELS
ABOVE NGML THAN AT NGML
OR LESS
N
LOWER LIFETIME RISK FOR
AUTOIMMUNE TYPE DIABETES IN
&INNISH CHILDREN GIVEN )5 OF
$ DAILY DURING lRST YEAR OF LIFE
)--5.% #%,, TREATED WITH
$ RESPONDS TO INFECTION BY
TUBERCULOSIS BACTERIA
AND
BY MAKING ANTIMICROBIAL
CATHELICIDIN PEPTIDES
"*9,/ÊÓääÇÊ-
ÃÌÀi`ÊÃiÀÕÊÃ>«iÃÊvÊÃiÊÃiÛiÊÊ1°-°Ê
ÀÞÊ>`Ê >ÛÞÊ«iÀÃiÊ>ÃÊÜiÊ>ÃÊÌ iÀÊ i>Ì Ê
ÀiVÀ`ÃÊÌÊÃiiÊÜ V Ê`Û`Õ>ÃÊ >`Ê`iÛi«i`Ê
-ÊLiÌÜiiÊ£ÓÊ>`ÊÓää{°Ê/ iÊÀiÃi>ÀV iÀÃÊ
vÕ`Ê>ÊÃ}wV>ÌÞÊÜiÀÊÀÃÊvÊ>ÌiÀÊ`iÛi«
}ÊÌ iÊ`Ãi>ÃiÊÊÌ iÊ}ÀÕ«ÊÜÌ Ê } ÊÃiÀÕÊ
Óx ÊiÛiÃÊ>ÌÊÌ iÊÌiÊÌ iÊÃ>«iÊÜ>ÃÊÌ>i°Ê-
`iÀÃÊÜÌ ÊÃiÀÕÊÓx ÊVViÌÀ>ÌÃÊ>LÛiÊ{äÊ
>}À>ÃÊ«iÀÊÌiÀÊ >`Ê>ÊÈÓÊ«iÀViÌÊÜiÀÊ
ÀÃÊÌ >ÊÌ iÊÃ`iÀÃÊÜ ÃiÊVViÌÀ>ÌÃÊ
ÜiÀiÊÓxÊ}ÉÊÀÊLiÜ°Ê
i>ÃÕÀ}ÊVÀVÕ>Ì}ÊiÛiÃÊvÊÓx ÊÃÊÌ iÊÕÃÕ
>ÊiÌ `ÊvÊ}>Õ}}ÊÛÌ>Ê Ê>Û>>LÌÞÊÊ
Ì iÊL`Þ°ÊiiÀ>ÞÊ>}Àii`ÊÊ i>Ì ÊÃÌ>`>À`Ã]Ê
L>Ãi`Ê>À}iÞÊÊLivÀ}Êii`Ã]Ê `ÊVÀVÕ
>Ì}ÊÓx ÊiÛiÃÊvÊÎäÊÌÊ{xÊ}ÉÊÌÊLiÊ
>ÞÊÃÕvwViÌ°Ê-iÀÕÊÛÌ>Ê ÊVViÌÀ>
ÌÃÊLiÜÊLiÌÜiiÊÓ£Ê>`ÊÓÊ}ÉÊ>ÀiÊVÃ`
iÀi`Ê ÃÕvvViÌÊ >`Ê vÌiÊ >VV«>i`Ê LÞÊ
`iVÀi>Ãi`ÊLiÊ`iÃÌÞ°Ê-iÊÃÞ«ÌÃÊvÊÀV
iÌÃÊ>ÞÊ>««i>ÀÊÜ iÊVViÌÀ>ÌÃÊv>ÊLiÜÊ
ÓäÊ}É]Ê>`ÊÌ iÊÀÃÊvÊVÊV>ViÀÊÀÃið
-ÕV ÊÜÊVViÌÀ>ÌÃÊ>ÀiÊÕvÀÌÕ>ÌiÞÊ
>ÊÌÊV]ÊiëiV>ÞÊÊÜÌiÀ°ÊÊiLÀÕ
>ÀÞÊ>`Ê>ÀV ÊvÊÓääx]ÊvÀÊiÝ>«i]Ê>ÊÃÕÀÛiÞÊvÊ
{ÓäÊ i>Ì ÞÊvi>iÃÊ>VÀÃÃÊÀÌ iÀÊ ÕÀ«i p Ê
i>ÀÊ «i >}i\ÊxxcÊ>ÌÌÕ`i®]Ê>`Ê
iÃ\ÊÈäc®]ÊÀi>`Ê À\ÊxÓc®Ê>`Ê*>`Ê
7>ÀÃ>Ü\ÊxÓc® p vÕ`ÊÌ >ÌÊÓÊ«iÀViÌÊvÊ>`
iÃViÌÊ}ÀÃÊÊÌ iÃiÊVÕÌÀiÃÊ >`ÊÓx ÊiÛiÃÊ
iÃÃÊÌ >ÊÓäÊ}ÉÊ>`ÊÌ >ÌÊÎÇÊ«iÀViÌÊvÊÌ iÊ
}ÀÃÊÜiÀiÊÃiÛiÀiÞÊ`iwViÌ]ÊÜÌ ÊÓx ÊiÛiÃÊvÊ
iÃÃÊÌ >Ê£äÊ}É°Ê}ÊÌ iÊ`iÀÊÜiÊ
ÌiÃÌi`]ÊÎÇÊ«iÀViÌÊÜiÀiÊvÕ`ÊÌÊLiÊÛÌ>Ê Ê
`iwViÌÊ>`Ê£ÇÊ«iÀViÌÊÜiÀiÊÃiÛiÀiÞÊ`iwViÌ°
iÞ`Ê>ÌÌÕ`i]ÊÃiÛiÀ>Êv>VÌÀÃÊV>ÊVÌÀL
ÕÌiÊÌÊÛÌ>Ê Ê`iwViVÞ]Ê>`Ê«À>ÀÞÊ>}Ê
Ì iÃiÊÃÊÀ>Vi°Ê7 ÌiÊÃÊÃÞÌ iÃâiÃÊÛÌ>Ê Ê
ÃÝÊÌiÃÊv>ÃÌiÀÊÌ >Ê`>ÀÊÃÊLiV>ÕÃiÊ } iÀÊ
iÛiÃÊvÊi>ÊÊ`>ÀiÀÊÃÊLVÊ16Ê«ii
ÌÀ>ÌÊQÃiiʺ-Ê ii«]»ÊLÞÊ >Ê°Ê>LÃÊ
>`ÊiÀ}iÊ >«ÆÊ3CIENTIlC !MERICAN
"VÌLiÀÊÓääÓR°ÊÃÊ>ÊÀiÃÕÌ]ÊvÀV>iÀV>ÃÊ
}iiÀ>ÞÊ >ÛiÊiÛiÃÊvÊÓx ÊÌ >ÌÊ>ÀiÊ>««ÀÝ
>ÌiÞÊ >vÊÌ ÃiÊvÊÜ ÌiÃÊÊÌ iÊ1°-°ÊÊv>VÌ]Ê
`>Ì>Ê}>Ì iÀi`ÊvÀÊÌ iÊ1°-°Ê >Ì>Êi>Ì Ê>`Ê
ÕÌÀÌÊ Ý>>ÌÊ-ÕÀÛiÞÊÃ Üi`ÊÌ >ÌÊ{ÓÊ
«iÀViÌÊvÊvÀV>iÀV>ÊÜiÊÌiÃÌi`ÊÜiÀiÊ
ÃiÀÕÃÞÊÓx Ê`iwViÌ]ÊÜÌ ÊÃiÀÕÊVViÌÀ>
ÌÃÊvÊiÃÃÊÌ >Ê£xÊ}É°Ê
VÀi>Ãi`Ê«ÕLVÊ>Ü>ÀiiÃÃÊÌ >ÌÊiÝViÃÃÛiÊiÝ
«ÃÕÀiÊÌÊÃÕ} ÌÊV>ÕÃiÃÊÃÊ`>>}iÊÃÊÕ
`ÕLÌi`ÞÊVÌÀLÕÌ}ÊÌÊÛÌ>Ê Ê`iwViVÞÊ
>ÃÊÜi°Ê7 iÊ«À«iÀÞÊ>««i`]ÊÌ«V>ÊÃÕ
ÃVÀiiÃÊÀi`ÕViÊÛÌ>Ê Ê«À`ÕVi`ÊÊÌ iÊÃÊ
/ Ê , ]Ê
°
.OVEMBER
0(),)0 ,)5 -!2)! 4%2%3! /#(/! !.$ 2/"%24 -/$,).
iÛiÃÊvÊÛÌ>Ê ÊÌ >ÌÊ>ÀiÊÜiÊLiÜÊ«Ì>Ê
VViÌÀ>ÌÃÊvÀÊ i>Ì ]Ê«>ÀÌVÕ>ÀÞÊ`ÕÀ}Ê
ÜÌiÀÊÌ Ã°Ê
16 Ê} ÌÊ«iiÌÀ>ÌiÃÊÌ iÊ>Ìë iÀiÊÀiÊ
`ÀiVÌÞÊÊÌ iÊÌÀ«VÃÊÌ >ÊÊÀiÊÌi«iÀ>ÌiÊ
Ài}ÃÊvÊÌ iÊ«>iÌ]ÊÜ V ÊÀiViÛiÊÃÕLÃÌ>Ì>Ê
>ÕÌÃÊvÊÌÊÞÊ`ÕÀ}ÊÌ iÊÃÕiÀ°Ê iV>ÕÃiÊ
ÃÌÊ«i«iÊLÌ>ÊÛÌ>Ê Ê>ÞÊÌ ÀÕ} Ê
16 ÊiÝ«ÃÕÀi]ÊVÀVÕ>Ì}ÊÓx ÊiÛiÃÊÊ««Õ
>ÌÃÊ}iiÀ>ÞÊ`Ã ÊÜÌ ÊVÀi>Ã}Ê>Ì
ÌÕ`i]Ê>Ì Õ} ÊÛ>À>ÌÃÊ>ÌÊ>Ê}ÛiÊ>ÌÌÕ`iÊ`Ê
>ÀÃiÊLiV>ÕÃiÊvÊ`vviÀ}ÊiÌ VÌiÃÊ>`Ê`iÌÃ]Ê
>ÃÊÜiÊ>ÃÊÛ>À>ÌÃÊÊV>ÊV>ÌiÊ>`ÊiiÛ>
Ì°Ê ÃÃÌiÌÊÜÌ ÊÛÌ>Ê ½ÃÊLÃiÀÛi`Ê}ii
Ài}Õ>ÌÀÞÊ>VÌÛÌiÃ]Ê>ÊVi>ÀÊ>ÃÃV>ÌÊÃÊÃiiÊ
LiÌÜiiÊVÀi>Ã}Ê>ÌÌÕ`iÊ>`ÊVÀi>Ãi`ÊÀÃÊ
vÊÃiÛiÀ>ÊiÃÃiÃ]ÊÃÌÊVëVÕÕÃÞÊ>ÕÌ
ÕiÊ`Ãi>ÃiÃÊÃÕV Ê>ÃÊ-°Ê
ÊV ÀVÊ«À}ÀiÃÃÛiÊiÃÃ]Ê-ÊÃÊV>ÕÃi`Ê
LÞÊÕiÊViÊ>ÃÃ>ÕÌÃÊÊÌ iÊ«ÀÌiVÌÛiÊÞ
iÊÃ i>Ì ÊÌ >ÌÊÃÕÀÀÕ`ÃÊiÀÛiÊwLiÀÃÊvÊÌ iÊ
ViÌÀ>ÊiÀÛÕÃÊÃÞÃÌi°ÊÌÃÊV`iViÊÃÊÃ}w
V>ÌÞÊ } iÀÊÊ>Ài>ÃÊv>ÀÌ iÃÌÊvÀÊÌ iÊiµÕ>ÌÀÊ
Ê ÀÌ ÊiÀV>]Ê ÕÀ«iÊ>`ÊÕÃÌÀ>>]Ê>`Ê
VÛV}ÊiÛ`iViÊÃÕ}}iÃÌÃÊÌ >ÌÊÌ ÃÊ«>ÌÌiÀÊ
ÀiÃÕÌÃÊvÀÊ`iVÀi>Ãi`Ê16 ÊiÝ«ÃÕÀi°Ê Ãi>ÃiÊ
«À}ÀiÃÃÊ>`ÊÃÞ«ÌÊy>ÀiÕ«ÃÊÊ-ÊÃÕv
viÀiÀÃÊ>ÃÊ`ë>ÞÊÜiiÃÌ>Là i`ÊÃi>Ã>Ê
Û>À>ÌÃ]ÊÜÌ ÊÌ iÊ } iÃÌÊ`Ãi>ÃiÊ>VÌÛÌÞÊÊ
Ì iÊëÀ}ÊÜ iÊVÀVÕ>Ì}ÊÓx ÊiÛiÃÊÜÕ`Ê
LiÊÜiÃÌÊvÜ}ÊÌ iÊÜÌiÀ®Ê>`ÊÌ iÊi>ÃÌÊ`Ã
i>ÃiÊ>VÌÛÌÞÊÊÌ iÊv>]Ê>vÌiÀÊÌ iÊÃÕiÀÌiÊ
LÃÌÊvÊ Î°ÊÀÊiÝ>«i]ÊÃViÌÃÌÃÊ>ÌÊÌ iÊ1
ÛiÀÃÌÞÊvÊ-ÕÌ iÀÊ >vÀ>ÊvÕ`Ê>ÊÛiÀÃiÊ
Ài>ÌÊ>}ÊÇÊ«>ÀÃÊvÊ`iÌV>ÊÌÜÃÊLi
ÌÜiiÊVÀi>Ãi`ÊÃÕÊiÝ«ÃÕÀiÊ`ÕÀ}ÊV ` `Ê
>`Ê>ÊviÌiÊÀÃÊvÊ`iÛi«}Ê-°Ê/ iÊÌÜÃÊ
Ü ÊëiÌÊÀiÊÌiÊÕÌ`ÀÃÊ>ÃÊV `ÀiÊ >`Ê
>ÃÊÕV Ê>ÃÊxÇÊ«iÀViÌÊÜiÀÊÀÃÊvÊ`iÛi«}Ê
Ì iÊV`Ì°
->ÀÊ«>ÌÌiÀÃÊvÊÀÃÊvÀÊiÃÃÊ >ÛiÊLiiÊ
`VÕiÌi`ÊvÀÊ>ÕÌÕiÊ`>LiÌiÃÊ>`ÊvÀÊ
À ½ÃÊ`Ãi>Ãi]Ê>Êy>>ÌÀÞÊ>ÕÌÕiÊ
ÌiÃÌ>ÊV`Ì]Ê>ÃÊÜiÊ>ÃÊvÀÊViÀÌ>ÊÌÞ«iÃÊ
vÊ>}>VÞ°Ê*«Õ>ÌÊÀ>ÌiÃÊvÊV>ViÀÃÊvÊ
Ì iÊL>``iÀ]ÊLÀi>ÃÌ]ÊV]ÊÛ>ÀÞÊ>`ÊÀiVÌÕÊ
VÀi>ÃiÊÌÜv`ÊvÀÊÃÕÌ ÊÌÊÀÌ ÊÊÌ iÊ1°-°]Ê
vÀÊÃÌ>Vi°Ê
Ê>``ÌÊÌÊÌ iÊ>ÞÊÃÌÕ`iÃÊVÀÀi>Ì}Ê
ÃÕÊiÝ«ÃÕÀiÊÜÌ Ê`Ãi>ÃiÊV`iVi]ÊÀiViÌÊ
ÛiÃÌ}>ÌÃÊ >ÛiÊ>`iÊÃ>ÀÊViVÌÃÊLi
ÌÜiiÊ`Ãi>ÃiÊÀÃÊ>`Ê`ÀiVÌÊi>ÃÕÀiiÌÃÊvÊ
VÀVÕ>Ì}ÊÓx ÊVViÌÀ>ÌÃÊÊL`ÊÃiÀÕ°Ê
ÊiÀÕÃÊÃÕÀÛiÞÊLÞÊÀiÃi>ÀV iÀÃÊ>ÌÊÌ iÊ>À
Û>À`Ê -V Ê vÊ *ÕLVÊ i>Ì Ê i`Ê >ÌÊ Ì iÊ
;',/"!, 02/",%-=
6)4!-). $ 7).4%2
%XPOSURE TO 56" RADIATION IN SUNLIGHT IS THE SINGLE GREATEST SOURCE OF
VITAMIN $ FOR MOST INDIVIDUALS SO LOCATION AND SEASON AFFECT A POPULA
TIONS RISK OF DElCIENCY &OR PERIODS OF THE YEAR KNOWN AS VITAMIN $
WINTER 56" INTENSITY IS TOO WEAK AT SOME LATITUDES EVEN TO INDUCE VI
TAMIN $ SYNTHESIS IN THE SKIN "ECAUSE OZONE BLOCKS 56" RAYS THE RAYS
ARE MOST INTENSE NEAREST THE EQUATOR WHERE SUNLIGHT TRAVELS THE LEAST
DISTANCE THROUGH THE EARTHS ATMOSPHERE AND VITAMIN $ SYNTHESIS IS
POSSIBLE YEAR ROUND !N INCREASING ANGLE OF PENETRATION AT HIGHER LATI
TUDES WEAKENS 56" INTENSITY UNTIL IT IS INSUFlCIENT ESPECIALLY DURING
WINTER FOR MAKING VITAMIN $
± -/2% 4/
%80,/2%
5NRAVELING THE %NIGMA OF 6ITAMIN
$ "EYOND $ISCOVERY 3ERIES .ATION
AL !CADEMY OF 3CIENCES
WWWBEYONDDISCOVERYORGCON
TENTVIEWARTICLEASPA
$IHYDROXYVITAMIN $ )S A $I
RECT )NDUCER OF !NTIMICROBIAL 0EP
TIDE 'ENE %XPRESSION 4IAN 4IAN
7ANG ET AL IN
6OL PAGES n
4HE 0LEIOTROPIC !CTIONS OF 6ITAMIN
$ 2OBERTO ,IN AND *OHN ( 7HITE IN
6OL .O PAGES n
*ANUARY
4HE 5RGENT .EED TO 2ECOMMEND
AN )NTAKE OF 6ITAMIN $ 4HAT )S
%FFECTIVE 2EINHOLD 6IETH ET AL IN
6OL .O PAGES n
-ARCH
6ITAMIN $ $ElCIENCY -ICHAEL &
(OLICK IN
6OL .O PAGES
n *ULY
,' 3 # ) % . 4 ) & ) # ! - % 2 ) # ! .
LÞÊÀiÊÌ >ÊnÊ«iÀViÌ°Ê Õ} ÊÛÌ>Ê ÊvÀÊ
}`Ê i>Ì ÊV>ÊLiÊÃÞÌ iÃâi`ÊÊÃÊÜÌ ÊÃÕÊ
iÝ«ÃÕÀiÊÌ >ÌÊ} ÌÊ«À`ÕViÊ>ÌÊÃÌÊ>ÊÃ} ÌÊ
«iÃÃ]Ê ÜiÛiÀ°ÊÀÊÃÌÊv>ÀÊ>`Êi`Õ
Ãi`Ê«i«iÊÊ ÀÌ ÊiÀV>]ÊÌ ÃÊÌ>iÃÊwÛiÊ
ÌÊ£xÊÕÌiÃÊvÊÃÕ} ÌÊLiÌÜiiÊ£ä\ääÊ°°Ê
>`ÊÎ\ääÊ*°°Ê`ÕÀ}ÊÌ iÊÃÕiÀÌi°
6Ì>Ê ÊÃÕ««iiÌÃÊVÕ`Ê>``ÀiÃÃÊÌ iÊ
} Ê«ÀiÛ>iViÊvÊÛÌ>Ê Ê`iwViVÞÊÊÌi
«iÀ>ÌiÊâiÃ]ÊLÕÌÊ ÜÊÕV Ê«i«iÊÃ Õ`ÊÌ>iÊ
ÃÊÃÌÊ>ÊÃÕLiVÌÊvÊ`iL>Ìi°Ê/ iÊiÀV>ÊV>`
iÞÊvÊ*i`>ÌÀVÃÊÀiVi`ÃÊ>ÊÕÊ`>
ÞÊÌ>iÊ, ®ÊvÊÓääÊÌiÀ>Ì>ÊÕÌÃÊ1®Ê
vÀÊV `Ài]ÊÜ V Ê>ÞÊÀiÃi>ÀV iÀÃÊ >ÛiÊ>À
}Õi`ÊÃÊÃÕL«Ì>]ÊiÛiÊvÀÊÀViÌÃÊ«ÀiÛiÌ°Ê
/ iÊ, ÊvÀÊ>`ÕÌÃÊÊ ÀÌ ÊiÀV>Ê>`Ê Õ
À«iÊVÕÀÀiÌÞÊÀ>}iÃÊLiÌÜiiÊÓääÊ1Ê>`ÊÈääÊ
1]Ê`i«i`}ÊÊ>}i°ÊvÌiÀÊÀiÛiÜ}ÊÕÌ«iÊ
ÃÌÕ`iÃÊV«>À}ÊÛÌ>Ê ÊÌ>iÊ>`ÊÌ iÊÃi
ÀÕÊVViÌÀ>ÌÃÊvÊÓx Ê«À`ÕVi`]Ê>ÀÛ>À`Ê
-V ÊvÊ*ÕLVÊi>Ì ÊÀiÃi>ÀV iÀÃÊ>`ÊÌ iÀÃÊ
VVÕ`i`Ê>ÃÌÊÞi>ÀÊÌ >ÌÊÌ iÊVÕÀÀiÌÊ, ÃÊ>ÀiÊ
>`iµÕ>Ìi°Ê/ iÞÊÃÕ}}iÃÌi`ÊÌ >ÌÊÊiÃÃÊÌ >Ê >vÊ
vÊ1°-°Ê>`ÕÌÃÊii`i`ÊÌÊVÃÕiÊ>ÌÊi>ÃÌÊ£]äääÊ
1ÊvÊÛÌ>Ê ÎÊ`>ÞÊÌÊÀ>ÃiÊÌ iÀÊÃiÀÕÊÓx Ê
VViÌÀ>ÌÃÊÌÊÌ iÊÕÊ i>Ì ÞÊiÛiÊvÊ
ÎäÊ}É°Ê ÊÀÕiÊvÊÌ ÕLÊiÝÃÌÃÊvÀÊV>VÕ>Ì
}ÊÌ iÊÃiÀÕÊÓx ÊiÛiÃÊ}iiÀ>Ìi`ÊLÞÊÃÕ««i
iÌÃ]ÊLiV>ÕÃiÊ`Û`Õ>ÊÀiëÃiÃÊV>ÊÛ>ÀÞÊ
>`Ê>ÞÊ`i«i`ÊÊ«>ÀÌÊÊÌ iÊiÝÌiÌÊvÊ`iw
ViVÞ°ÊÊÃÌÕ`ÞÊvÊ«Ài}>ÌÊÜiÊà Üi`]ÊvÀÊ
iÝ>«i]ÊÌ >ÌÊ`>ÞÊ`ÃiÃÊvÊÈ]{ääÊ1ÊÀ>Ãi`ÊÃi
"*9,/ÊÓääÇÊ-
ÀÕÊÓx ÊiÛiÃÊ`À>>ÌV>ÞÊÕÌÊÌ iÞÊÀi>V i`Ê
>LÕÌÊ{äÊ}ÉÊ>`ÊÌ iÊiÛii`Êvv°Ê6Ì>Ê ÓÊ
>ÃÊ>ÃÊLiiÊvÕ`ÊÌÊLiÊiÃÃÊivviVÌÛiÊÌ >Ê ÎÊ
>ÌÊÀ>Ã}Ê>`ÊÃÕÃÌ>}ÊÃiÀÕÊÓx ÊVViÌÀ>
ÌÃÊÛiÀÊÌi°Ê
/ÝVÊÛÌ>Ê ÊÛiÀ`ÃiÊÌ ÀÕ} ÊÃÕ««i
iÌ>ÌÊÃÊViÀÌ>ÞÊ«ÃÃLi]Ê>Ì Õ} ÊÌÊÃÊ
}iiÀ>ÞÊÃiiÊÜ iÊ`ÃiÃÊvÊ{ä]äääÊ1ÊÀÊÀiÊ
vÊ Ê >ÛiÊLiiÊÌ>iÊ`>ÞÊvÀÊ>ÊiÝÌi`i`Ê«i
À`°Ê-ÕÃ i`ÕVi`ÊÛÌ>Ê ÊÌÝVÌÞÊ >ÃÊ
iÛiÀÊLiiÊLÃiÀÛi`]Ê ÜiÛiÀ°Ê/Ê«ÕÌÊÌ ÃÊÊ
«iÀëiVÌÛi]Ê>Ê>`ÕÌÊÜ>ÊÜÌ ÊÜ ÌiÊÃÊ
iÝ«Ãi`ÊÌÊÃÕiÀÊÃÕÊÜ iÊÜi>À}Ê>ÊLÊ
}iiÀ>ÌiÃÊ>LÕÌÊ£ä]äääÊ1ÊvÊÛÌ>Ê ÊÊ£xÊ
ÌÊÓäÊÕÌiðÊ}iÀÊiÝ«ÃÕÀiÃÊ`ÊÌÊ}iiÀ
>ÌiÊ } iÀÊ>ÕÌÃÊvÊÛÌ>Ê ]ÊLiV>ÕÃiÊ16 Ê
} ÌÊ>ÃÊ`i}À>`iÃÊÌ iÊÛÌ>]Ê«ÀiÛiÌ}ÊÌÊ
ÕV ÊvÊÌÊvÀÊLÕ`}ÊÕ«ÊÊÌ iÊðÊ
VVÕÕ>Ì}ÊiÛ`iViÊÃÕ}}iÃÌÃÊÌ >ÌÊÌ iÊÃÕL
ÌiÊ>`Ê}iÀÌiÀÊivviVÌÃÊvÊiÛiÊÃ} ÌÊÛÌ>Ê
Ê`iwViVÞÊ>ÞÊLiÊÕÌv`Ê>`Ê>viÃÌi`Ê
>ÌiÀÊÊvi]ÊÊÌ iÊvÀÊvÊVÀi>Ãi`ÊvÀiµÕiVÞÊ
vÊLiÊvÀ>VÌÕÀiÃÊ>`Êi >Vi`ÊÃÕÃVi«ÌLÌÞÊÌÊ
viVÌÊ>`Ê>ÕÌÕiÊ`Ãi>ÃiÃ]Ê>ÃÊÜiÊ>ÃÊ
iiÛ>Ìi`ÊvÀiµÕiViÃÊvÊViÀÌ>ÊV>ViÀðÊ/ iÊÀi
Ãi>ÀV ÊÃÌÀ}ÞÊ«iÃÊÌ >ÌÊ>ÌÊÌ iÊÛiÀÞÊi>ÃÌÊÌ iÊ
}iiÀ>Ê«ÕLVÊÜÕ`ÊLiiwÌÊÃÕLÃÌ>Ì>ÞÊvÀÊ
}Ài>ÌiÀÊ>Ü>ÀiiÃÃÊvÊÌ iÊLÀ>`Ê« ÞÃ}V>Ê
LiiwÌÃÊvÊÛÌ>Ê ]Ê>ÊÃÕ`Êi`V>ÊVÃi
ÃÕÃÊÊÃiÃLiÊÃÕÊiÝ«ÃÕÀiÊ>`Ê>ÊVi>ÀÊ`V>
ÌÊvÊ«Ì>ÊÀiVi`i`Ê`>ÞÊÌ>iÃÊvÊ
ÛÌ>Ê ÊvÀÊ`iÌ>ÀÞÊÃÕÀViðÊÊ
/ Ê , ]Ê
°
.OVEMBER
,5#9 2%!$).' )++!.$!
Purchase answer to see full
attachment